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“There is nothing like looking, if you want to find 
something. You certainly usually find something, if you 
look, but it is not always quite the something  
you were after.” 
 
J.R.R. Tolkien 
 
 
 
 
 
 
 
 
 
          
 
 
 
 
           Till Sis…  
  
 
 
 
  
  
Abstract 
The calcium ion (Ca2+) is a highly versatile signaling messenger involved in a diverse 
range of physiological processes such as gene transcription/expression, 
proliferation, differentiation and cell death. Intracellular Ca2+ signals are generated 
through a 10 000 – 20 000 fold gradient across the cell membrane and via release 
from the external milieu and/or internal Ca2+ stores. Cells have a unique signaling 
toolkit to control Ca2+ homeostasis including a selection of ion channels, pumps, 
exchangers and Ca2+ binding proteins.  
 
We have reported that ouabain, an endogenous steroid hormone and ligand to the 
Na+,K+-ATPase, can trigger dendritic growth in cortical neurons through signal 
transduction. This involves a Ca2+-dependent transcriptional program regulated by 
CREB and CRE-mediated gene activation, primarily regulated through 
Ca2+/calmodulin-dependent protein kinases. The process also includes Ca2+ 
oscillations and phosphorylation of mitogen-activated protein kinases (ERK 1/2). 
These data suggest a novel role for Na+,K+-ATPase and Ca2+ in dendritic growth 
during development.  
 
Previous work has shown that treatment with protein kinase C (PKC) inhibitors 
results in a prolonged Ca2+ increase leading to calpain activation and release of 
apoptosis-inducing factor (AIF). We have demonstrated that hyperpolarization-
activated cyclic nucleotide-gated (HCN) channel 2 is responsible for the Ca2+ influx. 
The influx is regulated via dephosphorylation of a residue in the intracellular C-
terminal. This data shows a novel role for HCN channel 2 in cell death and a new 
possible drug target.  
 
Bladder cancer is overall one of the ten most common cancers. We have shown that 
treatment with Bacillus Calmette-Guerin (BCG), currently the most effective 
intravesical agent against bladder cancer, induces an intracellular Ca2+ increase and 
reduces cell proliferation in urinary bladder cancer (T24) cells. Store depletion by 
SERCA inhibition blocked the BCG-triggered signal, thereby suggesting a role of the 
endoplasmic reticulum as a Ca2+ source. This signaling event was dependent on 
phospholipas C since pharmacological inhibition or small interference RNA-mediated 
gene silencing abolished the response. Finally EdU incorporation revealed that BCG-
controlled cell proliferation was mediated via a Ca2+- and PLC-dependent signaling 
cascade. 
 
In summary this thesis presents three studies highlighting three different roles for 
Ca2+ signaling. They show that Ca2+ signaling is involved in processes critical for cell 
differentiation, cell proliferation, and cell death, three aspects highly coordinated 
with development and disease. 
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1 Introduction 
1.1. Calcium signaling 
”Kalzium? Ja, das ist alles!”  
O. Loewi 
 
The foundation for our current understanding of the multiple roles of calcium ions 
(Ca2+) was established by Sydney Ringer in the late 19th century. Ringer discovered 
that Ca2+ ions are crucial for regulation of heart contraction through the finding that 
a frog heart was able to beat when put in tap water but not in distilled water. 
Around the same period of time he also found that Ca2+ ions are involved in other 
processes like regulation of fertilization, tadpole development and to determine 
survival of fishes (Ringer, 1883a; Ringer, 1883b; Ringer, 1886; Ringer, 1890; Ringer 
and Sainsbury, 1894). Today the understanding and knowledge of Ca2+ signaling and 
its role in cellular processes is considerably broader.  
 
Ca2+ is one of, if not the most versatile second messenger signaling molecule. It is 
involved in the activation/regulation of a wide range of physiological processes such 
as differentiation, exocytosis, gene expression/transcription, memory, muscle 
contraction, proliferation and cell death (Berridge et al., 2003). The great diversity of 
Ca2+ signals associated with these processes is a result of complex regulation 
mechanisms of Ca2+ signals (i.e. Ca2+ concentration within the cell and changes in the 
concentration) in space, time and amplitude (Berridge et al., 1998; Boulware and 
Marchant, 2008).   
 
1.1.1. Calcium signaling toolkit 
A healthy cell at rest normally exhibits a 
cytoplasmic Ca2+ concentration around 100 
nM while the extracellular concentration is 
between 1 and 2 mM, which creates a 10 000 
– 20 000 fold Ca2+ gradient across the 
membrane. Upon activation the cytoplasmic 
concentration can rise to about 1000 nM. 
Different cytoplasmic compartments have a 
unique Ca2+ concentration (Figure 1.).                    Figure 1. Cellular Ca2+ homeostasis 
 
The Ca2+ homeostasis within a cell is a result of highly coordinated signaling via a 
large number of Ca2+ regulators (Box 1.). Each cell type expresses a unique set of 
regulators. This set of regulators is not totally fixed and can be remodeled 
depending on the need. Furthermore the signaling toolkit can more or less be 
divided into four different parts:  
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1. Encoding – The conversion from stimuli to a Ca2+ signal 
2. The ON mechanisms – the Ca2+ influx resulting in an elevation of intracellular 
Ca2+ 
3. Decoding – the process which transforms the encoded information from the 
Ca2+ signal into the physiological target response 
4. The OFF mechanism – the removal of Ca2+ to restore basal intracellular Ca2+ 
levels 
Figure 2. Cellular regulators for Ca2+ signaling 
1.1.1.1. Encoding 
The encoding process involve the generation of Ca2+ signals in response to a diverse 
range of stimulus. Here it refers to activation of channels permeable to Ca2+ e.g. 
Inositol 1,4, 5-trisphosphate (InsP3) will activate Inositol 1,4,5-trisphosphate 
receptor (InsP3R) that in turn will initiate the ON mechanism.  
 
1.1.1.2. The ON mechanism 
An elevation of intracellular Ca2+, also referred to as the “ON” mechanism, can be 
generated from two sources; the external milieu and/or internal stores. Ca2+ can 
enter the cell from outside via a variety of plasma membrane channels. The most 
studied type of channel is voltage-operated Ca2+ channels (VOCCs). They are found in 
excitable cells and generate a fast Ca2+ flux due to activation through depolarization 
of the plasma membrane, which occurs for example during muscle contraction and 
exocytosis. Another group of channels are the receptor-operated Ca2+ channels 
(ROCCs) which are activated via binding of external stimuli to the receptor. An 
example is the NMDA receptor that is activated by glutamate in neurons. A third 
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type of channels is the second messenger-operated Ca2+ channels (SMOCs). These 
are regulated by intracellular messengers (cAMP, cGMP) and include the cyclic-
nucleotide gated channels found in sensory systems and hyperpolarization-activated 
cyclic nucleotide-gated channels found in neurons and cardiomyocytes. Beyond the 
range of channels mentioned here, there are other channels also contributing to the 
Ca2+ homeostasis in the cell (Box 1) (Berridge et al., 2003; Bootman et al., 2001). 
 
The release of Ca2+ from internal stores mainly occurs from the sarco-/endoplasmic 
reticulum (SR/ER) through InsP3R and ryanodine receptor (RyR). They can be 
regulated by a variety of factors but are also sensitive to Ca2+ itself and are therefore 
involved in Ca2+ induced Ca2+ release (CICR) (Berridge et al., 2003; Bootman et al., 
2001; Mikoshiba, 2007). 
 
1.1.1.3. Decoding 
After the ON mechanism has generated a Ca2+ signal, the signal is decoded in order 
to activate a physiological response. Ca2+ is an ion and cannot itself be modulated. 
Instead the binding of Ca2+ to Ca2+-binding proteins can modulate the conformation 
and charge of the protein and thereby alter its function. Ca2+-binding proteins can be 
divided into two groups; Ca2+-sensors and Ca2+-buffers. Ca2+-sensors will undergo 
conformational changes due to Ca2+ binding and are involved in the decoding 
process and activate different cellular processes. In contrast Ca2+ buffers will only 
undergo a minor conformational change and therefore function as buffers or 
transporters. 
 
One of the most global sensor proteins is calmodulin. Calmodulin interacts with 
more than 100 different target proteins and is thus involved in the regulation of 
many different processes like gene transcription, ion channel modulation, muscle 
contraction, crosstalk among signaling pathways etc (Berridge et al., 2000).  
 
Calmodulin has four EF hands that can bind Ca2+, two in the N-terminal and two in 
the C-terminal. Interestingly the C-terminal EF hand pair has a three- to five-fold 
higher affinity for Ca2+ than for the N-terminal pair. Calmodulin partially performs it 
tasks by regulating diverse effector proteins.  Binding to effector proteins will 
increase calmodulins affinity for Ca2+ and thereby change the Ca2+ content in the 
complex. Protein kinases, phosphodiesterase, calcineurin, RyR, InsP3R are examples 
of effector proteins regulated by calmodulin and they can be divided into different 
classes depending on their mode of regulation in the absence or presence of Ca2+.  
 
Calmodulin can be regulated by Ca2+ in three different levels; cellular, intermolecular 
and sub-molecular. First, at cellular level changes in intracellular Ca2+ redistribute 
calmodulin within the cell. In muscle cells and neurons an influx of Ca2+ can lead to 
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intracellular redistribution from the cytoplasm to the nucleus. Second, at 
intermolecular level it will be regulated by supporting different types of interactions 
with a variety of effectors e.g. different downstream proteins. Third, when Ca2+ 
binds to calmodulin the conformation is changed which triggers target-specific 
activation. An example of this is calcineurin which forms an inactive low-affinity 
complex with calmodulin during low Ca2+ concentrations. In contrast in high Ca2+ 
concentrations the complex will adopt a high-affinity complex and calcineurin and 
will be activated by calmodulin (Chin and Means, 2000). 
 
Other Ca2+-sensor proteins can have more specific functions, for example 
synaptotagmin which regulates exocytosis (Zhang et al., 2010). 
 
1.1.1.4. The OFF mechanism 
When the desired signal is achieved the basal Ca2+ levels are restored through the 
“OFF” mechanism. This includes the plasma membrane Ca2+-ATPase (PMCA), 
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), Na+/Ca2+ exchanger (NCX), 
mitochondrial uniporter and binding to cytosolic buffering proteins (Berridge et al., 
2003; Berridge et al., 2000; Guerini et al., 2005; Wuytack et al., 2002). The off 
mechanism is crucial since elevated Ca2+ levels for longer times is toxic for the cell 
and can induce cell death.  
 
The PMCA pump is a transmembrane protein found in the plasma membrane that 
belongs to the family of P-type ATPases and exists in two conformational states (E1 
and E2). The E1 state, where the Ca2+ binding site is directed toward the cytoplasm 
and  binds Ca2+ with high affinity  and the E2 state where Ca2+ is released to the 
external milieu by decreased Ca2+ affinity. Four PMCA (PMCA1-4) isoforms have 
been discovered; PMCA1 and PMCA4 are ubiquitously expressed whereas PMCA2 
and PMCA3 are primarily expressed in the nervous system (Guerini et al., 2005). 
 
The NCX has nine transmembrane segments and is found in the plasma membrane 
and in the outer mitochondrial membrane. The task for the NCX is to export one Ca2+ 
in the exchange of 3 Na+, using the Na+ gradient as an energy source. On the other 
hand the direction of the NCX transport can be reversed if necessary e.g. if the Na+ 
gradient decreases and/or the membrane potential shifts towards a more positive 
value. The NCX exist in three isoforms, NCX1-NCX3. NCX1 is expressed in the heart, 
NCX2 in the brain and NCX in skeletal muscles (Guerini et al., 2005; Kimura et al., 
2009; Quednau et al., 1997).  
 
The SERCA pump is also a transmembrane protein belonging to the P-type ATPase 
although it is found in the membrane of sarco/endoplasmic reticulum where it 
pumps Ca2+ from the cytoplasm in to the SR/ER. The pump mechanism includes 
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transport of two Ca2+ ions across the membrane utilizing the energy from one ATP 
hydrolysis. Mammals express three SERCA genes which are spliced into a range of 
isoforms. Today at least 10 different isoforms has been detected at the protein level. 
SERCA1 and its two isoforms are mostly expressed in fast skeletal muscle, SERCA 2 
including its three isoforms are mainly found in cardiac tissue and slow skeletal 
muscles while SERCA3 and its six isoforms are expressed in several non-muscle 
tissues and have been found in hematopoietic cell lineages, platelets, epithelial cells, 
fibroblasts, and endothelial cells (Periasamy and Kalyanasundaram, 2007; 
Vangheluwe et al., 2005; Wuytack et al., 2002).  
 
The mitochondrial uniporter is found in the inner mitochondrial membrane. It is 
slower than other ion channels and has a turnover number 1000-fold lower than an 
ion channels (>105 s-1). The Ca2+ transport is in line with the electrochemical gradient 
sustained across the inner membrane and does not involve ATP utilization or co-
transport of other ions (Kirichok et al., 2004).  
 
Both the PMCA and SERCA pumps have low transport rates although Ca2+ binds with 
high affinity and thus they are able to respond to small changes in Ca2+ 
concentration. In contrast the NCX and mitochondrial uniporter have high transport 
rates and lower affinity and consequently limits Ca2+ transient over a wider dynamic 
range.  
 
The Ca2+ buffering proteins that become loaded during the ON mechanism become 
unloaded during the OFF mechanism. However, cytosolic buffers can modulate both 
the amplitude and duration of Ca2+ signals. Three buffer proteins are calretiinin, 
calbindin D and parvalbumin. The two first are fast buffers while parvalbumin is 
acting slower but binds Ca2+ with higher affinity (Berridge et al., 2003; Berridge et al., 
2000; Carafoli et al., 2001; Ikura et al., 2002; Lewit-Bentley and Rety, 2000).  
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Box 1. Ca2+ signaling regulators 
ON MECHANISM 
Channels  
Voltage-operated channels (VOCs) L-, P/Q-, N-, R- and T-type  
Receptor-operated channels (ROCs) NMDA receptors, ATP receptors 
Second-messenger-operated channels (SMOCs) CNG, HCN 
Transient receptor potential (TRP) ion-channels  TRPC1-7, TRPV1-6,TRPM1-8 
Inositol-1,4,5-trisphophate receptors (InsP3Rs) InsP3R1-3 
Ryanodine receptors (RyRs) RyR1-3 
 
OFF MECHANISM 
Pumps and exchangers  
Plasma membrane Ca2+-ATPases (PMCAs) PMCA1-4 
Sarco/endoplasmic reticulum Ca2+-ATPases 
(SERCAs) 
SERCA1-3 
Na+/Ca2+ exchangers (NCXs) NCX1-3 
Mitochondrial channels and exchangers Uniporter, NCX 
Golgi pumps SPCA1, SPCA2 
 
OTHER MEDIATORS 
Receptors GPCR: muscarin-, antgiotensin-, bradykinin-, histamine-, 
metabotropic glutamate-, extracellular Ca2+ sensing-, 
leukotrien-, neurotensin receptors 
Tyrosine-kinase-linked: platelet-derived growth factor 
receptors, epidermal growth factor receptors 
Transducers G-proteins, phospholipase C (PLC), ADP ribosyl cyclase, 
Regulators of G-protein signaling  
Calcium buffers Cytosolic: CalbindinD-28, celretinin, parvalbumin,  
ER/SR: calnexin, calreticulin, GRP 78 
Calcium effectors Calmodulin, troponin C, synaptotagmin, S100, annexin, 
meuronal Ca2+ sensor, hippocalcin 
Calcium-sensitive 
enzymes and processes 
Ca2+ regulated enzymes : CaMK, myosin ligh chain kinase, 
phosphorylase,Adenylyl cyclase, PYK2, PKC,nitric oxide 
synthase, calcineurin, phophodiesterase,  
Transcription factors: NFAT, CREB, CBP, DREAM 
 
1.1.2. Temporal and spatial input on calcium signaling  
Different spatial and temporal aspects contribute to the versatility of the Ca2+ 
signaling. Intracellular Ca2+ signals can occur in many shapes and forms but can very 
generally be grouped into three classes; transients, oscillations and sustained signals 
(Uhlen and Fritz, 2010). Ca2+ oscillations refers to multiple repeats of Ca2+ peaks that 
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can have different modulation of frequency and amplitude and can be induced by 
compounds like α-haemolysine (Uhlen et al., 2000), ouabain (Aizman et al., 2001) 
and testosterone (Estrada et al., 2006). 
 
Timing is central for Ca2+ signaling. Distinct processes can have a remarkable variety 
in the temporal range, lasting microseconds (e.g. exocytosis), minutes or hours (e.g. 
gene transcription, differentiation, proliferation) or even up to months or years (e.g. 
memory processes). Depending on the temporal pattern different types of 
cytoplasmic Ca2+ signal will arise. However, this is dependent on how the encoding 
process interpreted the signals and transferred them into cytoplasmic Ca2+ signals. 
Furthermore the frequency of the signal contributes towards the selection of which 
effectors  that will be activated and thereby vary the physiological output of the 
signal (Boulware and Marchant, 2008). Two proteins that are involved in decoding 
the frequency are CaMKII and PKC (De Koninck and Schulman, 1998; Oancea and 
Meyer, 1998). Dolmetch et al. demonstrated that low frequency Ca2+ signals 
activates NF-κB while NFAT was activated at a higher frequency rate (Dolmetsch et 
al., 1998). 
 
Ca2+ signals can have spatial ranges from nanometer to centimeter. Ca2+ “blips”, 
“puffs” and waves (more discussed in next section) are example of Ca2+ signals with 
different spatial pattern (Bootman et al., 1997).  
 
The amplitude of Ca2+ signals can also be interpreted into information. However 
because of the difficulty to distinguish small Ca2+ peaks from the background noise, 
signals that are modulated through changes in the amplitude are less reliable 
(Berridge et al., 1998).  
 
1.1.3. Inositol 1,4,5-trisphosphate receptor and Inositol 1,4,5-
trisphosphate  
In 1979 a protein named P400 was purified by Mikoshiba et al. which was later 
identified as the Inositol 1,4,5-trisphosphate receptor (InsP3R) (Maeda et al., 1988; 
Mikoshiba et al., 1979). Its main regulator Inositol 1,4,5-trisphosphate (InsP3) was 
discovered in the early 1980s (Streb et al., 1983). 
 
The InsP3R is an intracellular ion channel found in the SR/ER membrane. It is a 
complex formed of four subunits (313 kDa each) that each consists of six membrane-
spanning helices that contribute to the ion-conducting pore. The cytosolic NH2 part 
can be divided into an InsP3 binding domain and a regulatory/suppressor domain. 
The suppressor domain will interact with the InsP3 binding domain and suppress the 
binding affinity for InsP3 (Mikoshiba, 2007).  
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Three different isoforms of InsP3R have been identified in mammals, InsP3R1-
InsP3R3. Multiple isoforms are found in most cell types (Blondel et al., 1994; Yamada 
et al., 1994; Yamamoto-Hino et al., 1994). Each isoform has a unique affinity for 
InsP3 (Newton et al., 1994). The binding of the suppressor domain to the binding 
domain is responsible for the isoform specific affinity for InsP3 (Mikoshiba, 2007). 
 
As mentioned earlier, InsP3R is involved in the Ca2+influx during the ON mechanism. 
Stimulation of cell-surface receptors (for example GPCRs or TKRs) activates 
phospholipase C (PLC). Active PLC in turn hydrolyses phosphatidylinositol 
bisphosphate (PIP2) to InsP3 and diacylglycerol (DAG). InsP3 will diffuse in the cell and 
bind to InsP3R in the SR/ER and results in an intracellular Ca2+ rise. Depending on the 
status of the receptor, different types of Ca2+ responses are generated (Fill, 2003; 
Foskett et al., 2007; Mikoshiba, 2007).   
 
Three different types of Ca2+ responses generated by InsP3R are blips, puffs and 
waves. A Ca2+ blip (last around 200 ms, has an amplitude < 30 nm and diffuse less 
than 2 micrometers) is generated from opening of a single InsP3R. Another response 
generated from clusters of 40-70 InsP3R is a Ca2+ puff (last for 500 ms, has an 
amplitude around 200 nm and is spread over 6 µm) (Bootman et al., 1997; Thomas 
et al., 1998). Finally a Ca2+ wave can be produced. This wave is produced through 
Ca2+ puffs that are spread within the cell (Mikoshiba, 2007). 
 
In addition to InsP3, InsP3R is regulated by Ca2+. The InsP3 released Ca2+ can in turn 
further promote activation of more InsP3R channels that release additional Ca2+ as a 
positive feedback. This phenomenon is called Ca2+ induced Ca2+ release (CICR) and is 
used to coordinate communication and activities among channels. CICR is involved 
in the formation of puffs and waves (Foskett et al., 2007). In addition to InsP3R the  
RyR is also able to accomplish CICR. 
 
Conversely, in addition to stimulating the InsP3R channel, Ca2+ can also have an 
inhibitory effect. The InsP3R cannot release Ca2+ if the intracellular concentration is 
to low (< 50 nM) or to high (10-100 µM) (Berridge et al., 2000; Foskett et al., 2007). 
However, evidence suggests that high Ca2+ concentration does not always have 
inhibitory effects and that the relationship may be more sigmoid than bell-shaped 
(Bootman and Lipp, 1999). 
 
1.1.4. Implication of calcium signaling in life and death 
Ca2+ signaling is involved in different cellular processes throughout life from 
fertilization until death. Some of these processes will be mentioned here. However 
the implications of Ca2+ signaling in neuronal development, cell death and cancer 
will be discussed further in separate sections.  
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1.1.4.1. Fertilization 
Ca2+ is involved in mammalian fertilization via the InsP3/Ca2+ pathway. Ca2+ 
oscillations are triggered when the sperm interacts with the egg. The sperm fusion 
with the oocyte activates PLCγ, which will hydrolyze PIP2 to InsP3 and DAG. InsP3 in 
turn will stimulate InsP3R and Ca2+ release from internal stores and CICR will sustain 
the oscillations for a couple of hours (Miyazaki et al., 1993). 
 
1.1.4.2. Differentiation 
In the early embryo development Ca2+ signaling initially contributes to the body 
polarity and pattern formation. Later in development, Ca2+ is involved in and 
controls the differentiation of specific cell types. Differentiation of cells into a special 
cell type requires various signals. Therefore it is important to generate a toolkit for 
each cells requirement. Ca2+ oscillation are for example involved in the 
differentiation of muscles and neurons (Buonanno and Fields, 1999). NFAT, a Ca2+ 
dependent transcription factor, is involved in the formation of septum and valves in 
the heart (de la Pompa et al., 1998).  
 
1.1.4.3. Proliferation 
Ca2+ is also involved in proliferation and in the regulation of the cell cycle, mainly in 
G1 and at the G1/S and G2/M transitions, via upstream regulation and activation of 
transcriptions factors involved in cell cycle (Roderick and Cook, 2008). The role of 
Ca2+ during proliferation is well studied in lymphocyte activation. Antigen binding to 
surface receptors (TCR) of the lymphocytes activates PLCγ and InsP3 is produced. 
InsP3 will recruit Ca2+ via InsP3R from internal stores and when the stores are empty 
there will be an external influx of Ca2+ via store operated Ca2+ channels (Feske, 
2007). 
 
1.1.4.4. Activation of transcription factors 
As mentioned above Ca2+ often controls the cellular fate via regulation and 
activation of transcription factors. Transcription factors that are regulated by Ca2+ 
during the cell cycle include FOS, JUN, MYC, NFAT (Roderick and Cook, 2008). In 
lymphocytes, Ca2+ stimulates calcineurin to dephoshorylate NFAT. 
Dephosphorylation of NFAT will translocate it to the nucleus and transcription of 
different genes can occur. CREB is another transcription factor that is regulated by 
Ca2+ (Berridge et al., 2000).   
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1.2. Calcium and neural development 
1.2.1. Neural development  
The neural development involves a huge amount of cellular and molecular signaling 
processes that will generate, shape and reshape the nervous system from early 
stages of embryogenesis until the end of life. The growth, branching and guidance of 
neural projections during development are controlled by complex mechanisms with 
both diffusible and local acting signaling molecules binding specific receptors. The 
neural projections will form axons or dendrites that are specialized for 
communication and will form synaptic contacts with other nerve cells to allow nerve 
impulses to be transmitted. 
 
1.2.2. The role of calcium in dendritic growth   
The involvement of Ca2+ in dendritic growth is comparatively a quite recent finding. 
Spontaneous Ca2+ activity occurs during a period of intense dendritic growth in 
neurons and emerging evidence suggests that Ca2+ is needed for the dendritic 
growth and branching throughout this period.  
 
An increase in intracellular Ca2+ is necessary to gain stability in the branching of 
embryonic retinal ganglion cells. First synaptic transmission contributes to an 
elevated intracellular Ca2+ level. This elevation, originating from the extracellular 
milieu, will induce a Ca2+-induced Ca2+ release (CICR) from internal stores which will 
contribute to stabilization of the branches (Lohmann et al., 2002). 
 
In addition, an intracellular Ca2+ elevation can affect dendritic growth via 
downstream regulators including for example Ca2+/calmodulin-dependent protein 
kinase (CaMK). CaMKII is a neuronal signaling protein highly expressed in the brain. 
CaMKIIβ is required to initiate branching of dendrites in both sympathetic neurons 
(Vaillant et al., 2002) and hippocampal neurons (Fink et al., 2003). However CaMKIIα 
restricts dendritic growth in frog tectal neurons and mammalian cortical neurons 
(Redmond et al., 2002; Wu and Cline, 1998).  
 
Another CaM kinase, CaMKIV which normally localized in the nucleus has also been 
reported to be involved in dendritic growth. Early cortical neurons require a Ca2+ 
influx through VOCCs to induce dendritic growth. However this growth was 
suppressed by a dominant negative form of CaMKIV and enhanced by a 
constitutively active form of CaMKIV. This effect was mediated through the 
transcription factor cAMP-response element binding protein (CREB) although 
activation of CREB alone is not sufficient to stimulate dendritic growth (Redmond et 
al., 2002).  
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In the search for other transcription factors involved in dendritic growth CREST 
(calcium-responsive transactivator) was found (Aizawa et al., 2004). CREST is a CREB-
binding protein (CBP) highly expressed in the developing brain (Hardingham et al., 
1999). Analysis of a CREST knockout mice brain showed defects in the dendritic 
growth in both cortex and hippocampus. In addition cortical neurons from CREST 
mutant animals displayed a reduced dendritic growth in response to depolarization 
stimuli. These data support a role for CREST in calcium-dependent dendritic growth 
(Aizawa et al., 2004).  
 
In addition to different transcription factors, the mitogen-activated protein (MAP) 
kinase signaling pathway has been implicated in dendritic growth. Activation of this 
pathway, via sustained activation of ERK 1/2, is crucial for protrusion and 
stabilization of new dendritic filopodia in hippocampus (Wu et al., 2001). Further 
activation of ERK1/2 is implicated during dendritic growth in both sympathetic 
neurons (Vaillant et al., 2002) and in cerebellar granule cells (Borodinsky et al., 
2003). 
 
The extracellular calcium-sensing receptor (CaSR) monitors the extracellular 
Ca2+level in several organs involved in Ca2+ homeostasis (e.g. parathyroid and thyroid 
glands). Furthermore, CaSR has been shown to be expressed in the developing 
nervous system although their functions there have been questioned. In 2008 Vizard 
et al. demonstrated that the CaSR has a crucial role in regulating the growth of 
neuronal processes in both the peripheral and central nervous systems. They found 
that CaSR are expressed in perinatal sympathetic neurons and the neurite growth 
was affected in vitro by altering the Ca2+ concentration via addition of CaSR agonists 
and antagonist. Similarly primary cultures from CaSR knockout mice revealed smaller 
neurite arbors compared to the wild-type control. In vivo data showed reduced 
density of sympathetic innervations of the iris CaSR knockout mice. Furthermore it 
was shown that hippocampal pyramidal neurons in mice, also expressing CaSR, had 
smaller dendrites after transfection with a dominant negative CaSR in organotypic 
cell cultures (Vizard et al., 2008). This study suggests that Ca2+ not only acts 
intracellularly but also extracellularly during neural development. 
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1.3. Calcium and cell death 
1.3.1 Cell death 
Cell death is a complex process with an extensive variety of mediators. It is a 
procedure that is essential for all living organism to be able to develop, grow and 
finally survive in an optimal way. There are several different types of cell death 
(some described below) which can occur alone or simultaneously. How the cell 
death occurs is determined by various factors for example different noxious signals, 
ATP concentration, cell type (Galluzzi et al., 2007). 
 
Apoptosis or type 1 cell death is a highly regulated form of cellular self-destruction, 
having a critical role in embryonic development, normal tissue homeostasis in adults 
and in the immune system. Early morphological signs of apoptosis are chromatin 
condensation and cell shrinkage. Later in the process the nucleus and cytoplasm 
undergoes fragmentation with blebbing of the plasma membrane. In the end, the 
cell will break up and form apoptotic-bodies that are recognized and engulfed by 
phgocytic cells (Kerr et al., 1972). However, the fragmentation of the DNA might not 
always occur (Galluzzi et al., 2007). Another type of cell death is autophagic cell 
death (type 2). It is a rather slow process where the cytoplasm is confiscated inside 
double-membrane vacuoles which result in a massive vacuolization of the 
cytoplasm. The vacuoles are finally digested by lysosomal hydrolases (Kroemer and 
Jaattela, 2005). A third type of cell death, necrosis (type 3), is characterized by 
irreversible cytoplasm and organelle swelling and rupture of the plasma membrane. 
The release of the cellular content to the neighboring tissue can stimulate a local 
inflammation. Necrosis has for a long time been distinguished from apoptosis by 
being considered as an unregulated process. Although today evidence suggests that 
necrosis can also take place in a more controlled procedure called necroptosis 
(Vanlangenakker et al., 2008). 
 
1.3.2. The role of calcium in cell death 
As mentioned before Ca2+ signaling has an important role in regulation the cellular 
fate and including regulation of cell death. The same Ca2+ signaling system operating 
in a normal cell is involved in cell injury. The first report that Ca2+ was involved in cell 
death was by Fleckenstein et al in 1974. They suggested that the overload in 
intracellular Ca2+ in myocytes might be part of the mechanism that causes the 
cardiac pathology seen after ischemia (Fleckenstein et al). Next, Nicholson et al. 
demonstrated that the substantial Ca2+ influx from the extracellular space into 
neurons had a role in the ischemic cerebellum (Nicholson et al., 1977). During the 
last 30 years the role of Ca2+ in different cell death pathways has been further 
established (reviewed by: (Choi, 1995; Eisner et al., 2006; Ermak and Davies, 2002; 
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Kristian and Siesjo, 1998; Nicotera and Orrenius, 1992; Norberg et al., 2008; 
Orrenius and Nicotera, 1994)).  
Following a cell injury pathological Ca2+ signals are generated. Usually these signals 
appear as a prolonged intracellular Ca2+ elevation. The Ca2+ elevation can be a result 
from Ca2+ overstimulation and/or failure to maintain Ca2+ homeostasis through an 
increased Ca2+ entry/release, compromised Ca2+ extrusion or a combination of 
these. The pathological Ca2+ signals can activate several intracellular pathways that 
trigger cell death and thus are involved in the selection of death process (apoptosis 
or necrosis). The choice of death process is decided by the severity of the injury and 
the status of the cell e.g. the resting concentration of ATP and the mitochondrial 
status (Orrenius et al., 2003). 
 
The mitochondria are involved in the regulation of a diversity of processes like ATP 
synthesis, steroid hormone synthesis, metabolism and Ca2+ homeostasis. A Ca2+ 
increase in the cytoplasm will also induce a mitochondrial Ca2+ uptake, mostly driven 
by mitochondrial inner membrane potential. This will lead to elevated Ca2+ levels in 
the mitochondrial matrix although the level will quickly return to basal levels when 
the intracellular elevation decreases (Duchen, 1999). The mitochondrial Ca2+ 
concentration is determined by uptake through the uniporter, the efflux through 
NCX and Ca2+ buffering activity in the matrix. These three things make it possible for 
the mitochondria to tightly control the Ca2+ homeostasis and also be involved in the 
regulation of spatial and temporal pattern of Ca2+ signals (Szabadkai et al., 2006).  
 
However mitochondrial Ca2+ can also be involved in cell death through permeability 
transition. A tolerant Ca2+ load in the mitochondrial matrix will result in opening of a 
permeability transition pore and thereby increase the permeability of the 
mitochondrial inner membrane to ions and solutes (≤ 1.5 kDa). This is most often 
followed by depolarization with Ca2+ release, matrix swelling and rupture of the 
outer mitochondrial membrane followed by release of cytochrome c and other 
apoptogenic proteins as AIF (Bernardi et al., 2006). 
 
1.3.3. Pathological calcium signals 
Extracellular influx of Ca2+ can quickly result in a toxic overload of Ca2+. Spontaneous 
cells death occurs during mammalian spermatogenesis through a massive Ca2+ influx 
through VOCCs (Barone et al., 2004). VOCCs are also involved in chromaffin cell 
death where a Ca2+ elevation through L-type VOCCs lead to mitochondrial disruption 
and cell death (Cano-Abad et al., 2001). Another example of channels involved in cell 
death is ROCCs. The glutamate receptor NMDA can trigger pathological Ca2+ 
overload in neuronal excitotoxic cell death (Hardingham, 2009). Finally transient 
receptor potential (TRP) channels have been shown to be involved in cell death 
processes in photoreceptors (Yoon et al., 2000). 
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Internal Ca2+ stores mostly ER also plays a role in pathological Ca2+ signals and cell 
death. Failure in ER Ca2+ handling will affect chaperones, alter protein folding which 
will introduce an ER stress response that in severe cases can result in cell death (Pahl 
and Baeuerle, 1997). Disturbance in ER Ca2+ homeostasis or gathering of proteins 
within the ER will activate caspase 12 which will stimulate apoptosis (Nakagawa and 
Yuan, 2000). One other example is InsP3R which is involved is during neuronal 
excitotoxic cell death, caused by hyper-activation of the NMDA receptors, where 
InsP3R activation aggravated the cell death (Mattson et al., 1989). InsP3R mediated 
Ca2+ release can also induce increases in mitochondrial Ca2+ which in turn can lead to 
release of different pro-apoptotic factors like cytochrome c, SMAC (second 
mitochondrial activator of caspases) and apoptosis-inducing factor.  
 
1.3.4. Apoptosis-inducing factor  
Apoptosis-inducing factor (AIF) is a mitochondrial protein with a double nature in 
controlling both cellular life and death. AIF functions as an anti-apoptotic factor via 
its NADH oxidase activity in healthy cells (Klein et al., 2002), whereas it also can 
function as a pro-apoptotic factor by its unique ability to induce caspase-
independent apoptosis (Joza et al., 2001).  
 
AIF is transcribed in the cytoplasm forming a 67 kDa precursor protein containing a 
mitochondrial localization signal (MLS) in the N-terminal domain. When imported 
into the mitochondria, the protein is processed by a mitochondrial peptidase to a 62 
kDa mature protein through removing the MLS (Otera et al., 2005). Within the 
mitochondria AIF is located in the intermembrane space where it is anchored in the 
N-terminal to the inner mitochondrial membrane (Otera et al., 2005). Removal of 
the MLS also exposes the flavine adenine nucleotide (FAD) domain which is required 
for its NADH oxidase activity (Miramar et al., 2001).  
 
Upon stimulation with specific death signals, AIF can be further processed and 
cleaved from the inner mitochondrial membrane by proteases (calpains) generating 
a 57 kDa soluble protein. Permeabilization of the mitochondrial outer membrane 
admits release of AIF to the cytoplasm (Otera et al., 2005; Susin et al., 1999). This 
process requires an increase in intracellular Ca2+ to occur (Norberg et al., 2008). 
 
Once released to the cytoplasm, AIF is translocated to the nucleus where it 
contributes to chromatin condensation and DNA fragmentation although the exact 
mechanism by which AIF acts remains unknown (Otera et al., 2005; Susin et al., 
1999). However, the important role of AIF in cell death has only been shown in 
certain types of cells such as neurons and some tumor cells (Norberg et al., 2010b).  
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1.4. Calcium signaling and cancer 
1.4.1. Cancer 
Cancer (or malignant neoplasm) is a term used for a group of diseases that displays 
uncontrolled growth due to defect mechanisms in cell proliferation and cell death. 
The cell growth can be limited to a certain location (e.g. an organ or tissue) or be 
invasive into surrounding tissues and sometimes also metastasis to more distal 
parts. The emergence of a tumor is a multistage process and genetic abnormalities 
and environmental factors are the two contributing factors. 
 
1.4.2. The role of calcium in cancer 
As mentioned above a tumor is formed by excessive cell proliferation in combination 
with evading cell death resulting in an imbalance in the tissue homeostasis and 
thereby uncontrolled cell growth (Hanahan and Weinberg, 2000). The regulation 
mechanisms behind these two processes are totally distinct. Proliferation is 
dependent upon cycline-dependent kinases (CDK’s), regulators of the cell cycle 
(Nigg, 1995), whereas caspases have a crucial role in apoptotic cell death (Nicholson, 
1999). Although these are two very distinct pathways they have one common actor 
playing a central role, namely Ca2+.  
 
Ca2+ signals have an important role in the regulation of both cell proliferation and 
cell death by its complex signaling system (Berridge, 1995; Berridge et al., 1998). The 
cell transformation of a healthy cell into a tumor cell is associated with alternations 
in the regulatory Ca2+ signaling system including reorganization of Ca2+ pumps, Ca2+ 
channels, NCX in the plasma membrane and SR/ ER (Berridge et al., 2003; Monteith 
et al., 2007). Further understanding of these changes and characterization of 
involved actors can be very helpful in perspectives of cancer treatment.  
 
1.4.2.1. Examples 
Blood supply is required for tumor growth. This occurs via angiogenesis, a process 
which requires Ca2+ regulation (Patton et al., 2003).  
 
CaSRs is involved in monitoring extracellular Ca2+ concentrations. In colon carcinoma 
and parathyroid hyperplasia altered levels of CaSR have been connected to 
dysfunctional growth suppressing effects induced by increased extracellular Ca2+ 
(Rodland, 2004). In addition CaSRs expression have been linked to proliferation in 
both parathyroid adenomas and carcinomas (Manning et al., 2006).  
 
PMCA pump alteration has been associated with tumorogenesis. Overexpression of 
PMCA restricts Ca2+ in internal stores and will also contribute to faster depletion of 
cytoplasmic Ca2+ (Brini et al., 2000). Human breast cancer cell lines show expression 
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levels of PMCA2 that are 100-fold higher than normal (Lee et al., 2005). PMCA 
expression is also altered in hepatocarcinomas (Delgado-Coello et al., 2003). 
 
Dysfunctional SERCA3 pump expression is related to colon carcinogenesis and 
unequal Ca2+ homeostasis is observed (Brouland et al., 2005). Decreased expression 
of SERCA2b pump is associated with increased malignancy and cell death evading is 
seen in the transformation of the prostate cell line LNCaP (Vanden Abeele et al., 
2002). 
 
1.4.3. Bladder cancer  
1.4.3.1. Statistics and risk factors  
According to GLOBOCAN worldwide cancer statistics (2008) bladder cancer is one of 
the 10 most commonly occurring cancer forms in Europe (9th place with an incidence 
of 4.3 %) while being 11th most common worldwide. However, it should be 
considered that the worldwide distribution of the bladder cancer varies greatly, with 
the highest incidence in industrialized countries. The incidence increase with age 
with a peak between 50 and 70 years and is approximately three times more 
frequent in males than in females (Ferlay J, 2008).  
 
The transformation from a healthy urinary bladder epithelium to a malignancy 
requires some type of carcinogenic stimuli; chemical/environmental, chronic 
irritation or genetic. Tobacco is the major carcinogenic contributor to bladder cancer 
development. Tobacco represents more than 50 % of cases (Burch et al., 1989). 
Other causative carcinogens are; aromatic amines often present in industrial 
chemicals (Golka et al., 2004; Rouissi et al., 2009), ionization radiation (pelvic 
radiotherapy) (Kaldor et al., 1995), Schistosoma haematobium infection (snail fever) 
(Lucas, 1982) etc.  
 
1.4.3.2. Symptoms and diagnosis 
The primary symptom of bladder cancer is painless haematuria (blood in the urine). 
Other symptoms are changed urinary frequency, urgency and dysuria. Severe 
haematuria should always be further examined. Diagnosis of bladder cancer includes 
both urological and imaging tests including cystoscopy and biopsy. The biopsy is 
analyzed according to the “tumor, node, metastases (TNM) system” (Table 1.) 
(Sexton et al., 2010).  
 
1.4.3.3. Treatment  
The treatment choice for bladder cancer depends on many different factors 
including type of cancer, stage of tumor and the overall health status and age of the 
patient. The various alternatives of treatments available today are surgery,  
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immunotherapy, chemotherapy, radiation or a combination of surgery with one of 
the others.  
 
Table 1. TNM Classification of Urinary Bladder Cancer (UICC 1997) 
Primary tumor (T) 
TX Primary tumor cannot be assessed  
T0 No evidence of primary tumor 
Ta Non-invasive papillary carcinoma 
TIS Carcinoma in situ  
T1 Tumor invades sub-epithelial connective tissue 
T2 Tumor invades the muscularis 
T2a Tumor invades superficial muscle (inner half) 
T2b Tumor invades deep muscle (outer half) 
T3 Tumor invades perivesical tissue 
T3a microscopically 
T3b macroscopically (extravesical mass) 
T4 
Tumor invades any of following: prostate, uterus, vagina, pelvic wall, 
abdominal wall 
T4a Tumor invades prostate, uterus, or vagina 
T4b Tumor invades pelvic wall or abdominal wall 
Regional Lymph Nodes (N) 
NX Lymph node cannot be assessed 
N0 No lymph node metastasis  
N1 Metastasis in single lymph node, ≤ 2 cm 
N2 
Metastasis in single lymph node, ≥2 cm but ≤5 cm / multiple lymph nodes, ≤ 
5 cm  
N3 Metastasis in a lymph node, ≥ 5 cm  
Distant Metastasis (M) 
MX Distant metastasis cannot be assessed 
M0 No distant metastasis 
M1 Distant metastasis 
 
For non-muscle-invasive bladder cancer, which represents 70-80 % of the cases 
(Simons et al., 2008), is the initial treatment surgery i.e. transurethral resection 
(TUR). However, tumor recurrence occurs in up to three quarters of the patients 
after TUR and in some cases the tumor further progresses to invasive muscle cancer 
(occurs in ~20 %) (Amling, 2001). In order to prevent this recurrence and 
progression, non-specific immunotherapy with intravesical installation of Bacillus 
Calmette-Guerin (BCG) is used. BCG is instilled into the bladder via a catheter.  
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According to bladder cancer treatment many meta-analysis have been conducted 
from different randomized clinical trials (Reviewed by (Ayres et al., 2010; Chade et 
al., 2009; Gontero et al., 2010; Morgan and Clark, 2010; Shelley et al., 2010)). In 
summary, currently the most effective intravesical agent to treat, prevent 
recurrence and further progression of bladder cancer is BCG, but only if 
maintenance therapy is applied. Maintenance therapy is necessary since the BCG 
triggered immune response will reduce with time. BCG maintenance is superior to 
chemotherapy with for example mitomycin C (anti-tumor antibiotic that inhibit DNA 
synthesis) although BCG has more severe and toxic side-effects.  
 
Two types of BCG induced side-effects can occur, either local or systematic. Local 
side-effects include cystitis (up to 90 % of all patients), irritating voiding symptoms, 
mild fever, prostatitis, haematuria. Systematic symptoms include flu-like symptoms 
(fever and malaise), although high fever can be connected with sepsis or 
hypersensitivity reaction which is the most severe side-effect as it can lead to 
multisystem organ failure and death (Hall et al., 2007; Rischmann et al., 2000; 
Sylvester, 2010; Talug et al., 2009). Both local and systematic side-effects can lead to 
interrupted BCG treatment. It should also be considered that not all patients will 
respond to BCG (BCG failures). Both withdrawal of BCG therapy and BCG failure 
greatly impair the prognosis.  
 
More severe bladder cancer that has spread to the surrounding tissue generally 
requires cystectomy (partial or entire removal of the bladder) and metastasized 
tumors even more radical treatments (Sexton et al., 2010; Sharma et al., 2009). 
 
1.4.3.4. Bacillus Calmette-Guerin  1.4.3.4.1. History of Bacillus Calmette-Guerin 
Bacillus Calmette-Guerin (BCG) is a live attenuated preparation from Mycobacterium 
bovis tuberculosis (Figure 3.) which was first used as a live vaccine against 
tuberculosis in 1921 by Albert Calmette and Camille Guerin at the Pasteur Institute 
in France (Calmette, 1926). 
 
The anticancer effect from BCG was first observed at post mortem autopsy showing 
a lower incidence of cancer in people treated for tuberculosis. It would take a 
further 50 years until the next publication about BCG in cancer treatment where it 
was shown that malign melanoma responded to BCG (Gutterman et al., 1973; 
Morton et al., 1970). However, the first effect on bladder cancer was shown in 1976. 
Morales et al. reported a reduction in recurrence of bladder cancer in 7 of 9 patients 
after intravesical treatment with BCG once a week for 6 weeks (Morales et al., 
1976). 
 
 19 
 
 
Figure 3. Mycobacterium tuberculosis 
(http://www.lookfordiagnosis.com/mesh_info.php?term=mycobacterium&lang=6) 
 1.4.3.4.2. Mechanisms 
BCG and its anticancer effect in bladder cancer has been closely studied over the last 
35 years but the exact mechanism of action remains elusive. However it is confirmed 
that intravesical administration of BCG gives rise to a local immune and 
inflammatory response in the bladder. The response includes various immune cells 
(macrophages, dendritic cells, lymphocytes, neutrophiles and NK cells) and elevated 
levels of cytokines and chemokines that in turn may account for the anticancer 
effects of BCG.  
 
Following instillation of BCG into the bladder recruitment of antigen presenting cells 
(dendritic cells, macrophages) will occur. Dendritic cells are the main antigen 
presenting cells for intracellular pathogens like BCG. BCG infected dendritic cells will 
release elevated levels of cytokines and chemokines that are of importance for T-
lymphocyte activation (Demangel and Britton, 2000). They will process BCG, release 
inflammatory cytokines/chemokines and present BCG for T-lymphocytes. 
 
Different reports support the theory that BCG-infected dendritic cells lead to T-
lymphocyte activation and elevated levels of IL-2, IL-8, IL-10, IL-12, INF-γ and TNF-α 
(Cheadle et al., 2003; Higuchi et al., 2009; Ramoner et al., 1998). This activation is 
dependent on presence of CD4+ and CD8+ T-lymphocytes to mediate the anticancer 
activity (Ratliff et al., 1993). 
 
This will in turn attract and activate other immune cells like γδT-lymphocytes and 
natural killer cells and neutrophiles (Naoe et al., 2007). γδT-lymphocytes represent a 
small group of T-lymphocytes expressing T-cell receptor (TCR) and are involved in 
both innate and adaptive immune responses while natural killer T cells are a 
subpopulation of T-lymphocytes expressing both NK cell markers and T-cell 
receptors and are primarily involved in the detection of bacterial and parasitic 
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pathogens (Munz et al., 2005). One hypothesis is that the elimination of tumor cells 
occurs through γδT-lymphocytes and natural killer T cells (via a pathway including 
stress-associated tumor specific MICA/MICB molecules and the NKG2D receptor) 
(Higuchi et al., 2009). 
 
TNF-related apoptosis inducing ligand (TRAIL), one molecule able to induce 
apoptosis in neoplastic but not healthy cells, is expressed and secreted from 
neutrophiles following BCG stimulation and seems to contribute to the anticancer 
effect (Kresowik and Griffith, 2009; Simons et al., 2008).  
 
Although the immune response is of great importance, perhaps even essential, for 
the anticancer effect, the direct interaction between BCG and the tumor should not 
be disregarded. It is possible the direct interaction might be crucial to trigger the 
immune response.  
 
BCG can interact directly with the tumor cells which is followed by internalization 
and degradation of BCG (Becich et al., 1991). In vitro studies have reported that BCG 
increases the expression of intracellular adhesion molecule (ICAM)-1, a molecule 
required for linking tumor cells with immune cells (T lymphocytes and neutrophiles) 
(Alexandrov AV, 1997; Jackson et al., 1994). Elevated levels of IL-6, IL-8, IL-16, GM-
CSF IFN-α, INF-γ have also been reported (Esuvaranathan et al., 1995; Zhang et al., 
1999). The IL-6 production might be regulated through a cAMP pathway and 
requires NF-κB activation (Chen et al., 2002; Zhang et al., 2002). In addition in vivo 
studies have reported amplified levers of IL-1, IL-6 and TNF-α due to BCG treatment 
(Esuvaranathan et al., 1995; Sander et al., 1996). 
 
Furthermore, introduction of BCG suppresses proliferation of bladder cancer cell in a 
dose and time dependent mode (Jackson, 1994) and induces caspase independent 
cell death with necrotic characteristics, including release of a typical necrosis marker 
protein (high molecular group box protein 1) (See et al., 2009). In contrast to the last 
study two other studies have reported that BCG itself is not able to induce cell death 
(Chen et al., 2007; Sasaki et al., 1997). In our current study we have shown that 
direct interaction between BCG and human bladder cancer cell line T24 results in 
reduced proliferation via PLC (unpublished data, paper III).  
 
On the other hand it should be considered that it is not established if a healthy 
bladder epithelium will response in the same way as a tumor cell or not.  
 1.4.3.4.3. Further perspectives 
Today the most prominent treatment of bladder cancer is BCG even if it has been 
hardly challenged with newer agents. However all available treatments including 
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BCG have serious limitations and needs to be improved. One of the most serious 
drawbacks with BCG is the severe side-effects. There are patients that cannot 
continue the treatment due to side-effects (around 20 %) because of the high 
toxicity of BCG. The massive release of cytokines and chemokines during the 
immune response might be of big contribution to the side-effect. To minimize the 
side-effects the optimal dose of BCG, the induction time and duration of the 
treatment need to be determined, although optimal treatments will vary from 
patient to patient. Deeper understanding of the anticancer effect and 
supplementary treatment with other agents might be alternative solutions. The 
failure of some patients to respond to BCG treatment is yet another drawback which 
will need to be resolved. 
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1.5. Maintenance of membrane potential  
There is an electrical potential or voltage across the plasma membrane in all living 
cells. This voltage is referred to as the resting membrane potential and is a 
consequence of unequal distribution of ions outside and inside the cells, the 
membrane permeability for those ions (i.e. ion conductions through ion channels) 
and active ion pumps. There is usually a higher concentration of potassium (around 
20 times higher) and different anions inside the cell and higher concentrations of 
sodium (about 10 times higher) and chloride outside the cell. This ion distribution 
gives, for example an excitable cell like a neuron a net negative charge and a resting 
membrane potential around -70 mV when it is not producing an action potential in 
neurons, muscle and heart cells is the resting membrane potential the driving force 
for communication and other processes (Wright, 2004). 
 
Two factors that are involved in the maintenance of the membrane potential are: i) 
the sodium pump or Na+,K+-ATPase and ii) hyperpolarization-activated cyclic 
nucleotide-gated channels.  
 
1.5.1. The sodium pump and its functions 
1.5.1.1. The sodium pump  
Na+,K+-ATPase or the sodium pump was first described in 1957 by Jens C Skou  (Skou, 
1957). In 1997 Jens C Skou was rewarded with the Nobel Prize in chemistry for his 
finding. The sodium pump is located in the plasma membrane in all mammalian cells 
where it transports cations against their concentration gradient; 3 Na+ out and 2 K+ 
in utilizing energy from one ATP. This process stands for around 30 % of the entire 
energy consumption in a cell. The pumping generates an electrical gradient across 
the plasma membrane and thereby making the sodium pump responsible for 
establishing and maintaining the electrochemical gradient and resting potential in 
cells (Scheiner-Bobis, 2002; Skou and Esmann, 1992). This gradient is essential for 
the excitability in muscles and brain cells, furthermore it drives many transport 
mechanisms of ions, amino acids, vitamins. Apart from this the sodium pump plays a 
fundamental role in many biological processes and has a very complex function.   
 
1.5.1.2. Structure of the sodium pump 
The sodium pump belongs to the same family as the PMCA and SERCA pumps, 
namely the P-type ATPase super-family (Lutsenko and Kaplan, 1995). The sodium 
pump consists of two main subunits, α & β and depending on tissue sometimes also 
a third, γ. The α subunit is a multispanning membrane protein that possesses the 
catalytical function of the enzyme and accounts for the transport of Na+ and K+. It 
exists in four isoforms (α1-4). The β subunit, a polypeptide, is the regulatory part of 
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the enzyme and is necessary for proper protein folding and integration into the 
plasma membrane. It exists in three isoforms (β1-3) (Blanco and Mercer, 1998; 
Kaplan, 2002; Sweadner, 1989). The γ subunit (an auxiliary subunit, belonging to the 
FXYD family) exist in some tissues where it modulates the enzymatic activity but it is 
not required for the functional enzyme activity (Geering, 2005; Geering, 2006). The 
presence or absence of the γ subunit is not fully established.  
 
Both α and β subunits are expressed in a tissue specific manner. The α1 isoform is 
ubiquitously expressed while the α2 isoform expression is restricted to skeletal, 
heart and smooth muscle, brain, lung and adipocytes. The α3 isoform is mainly 
found in neurons and ovaries and α4 isoform is expressed in sperm (Kaplan, 2002; 
Lingrel and Kuntzweiler, 1994; Sweadner, 1989; Woo et al., 1999).  
 
1.5.1.3. Cardiotonic steroids  
Cardiotonic steroids (CTS) are a group of compounds naturally found in plants and 
including digitoxin, digoxin and around 250 other compounds (Krenn and Kopp, 
1998). Digitalis is also known as digoxin, an extract from Digitalis purpurea (Foxlove) 
(Figure 4.), which has been used to treat arrhythmias 
and congestive heart failure for more than 200 years.  
 
CTS acts by binding to the extracellular loops of α 
subunit in the sodium pump inducing a 
conformational change and thereby inhibiting the 
pump in a dose-dependent manner.  
This leads to an increase in the intracellular Na+                                       
concentration which in turn elevates the intracellular  
concentration of Ca2+ via the Na+/Ca2+-exchanger 
which in turn increases the cardiac output (Blaustein, 
1993).                                    
       Figure 4. Digitalis purpurea                                                                                                                                             
 
In 1991 Hamlyn and coworkers reported the occurrence of endogenous ouabain in 
human plasma (Hamlyn et al., 1991). Thereafter endogenous ouabain or ouabain-
like material has been found in the bovine adrenal gland and bovine hypothalamus 
(Schneider et al., 1998; Tymiak et al., 1993) and most recently in rat 
adrenomedullary cells (Komiyama et al., 2001). Mass spectroscopy and nuclear 
magnetic resonance experiments have reported that the endogenous ouabain is 
identical to the plant-derived ouabain. It is considered that the endogenous ouabain 
is synthesized in the adrenal gland and in the hypothalamus even if the total process 
has not been identified (el-Masri et al., 2002; Komiyama et al., 2001; Murrell et al., 
2005). Endogenous ouabain has hormonal functions and has been established to 
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have similar function as CTS i.e. binding and inhibiting the sodium pump in a dose-
dependent manner. Distinct from other proteins ouabain are not able to penetrate 
the plasma membrane.  
 
The amino acid sequence of the CTS binding site is highly conserved during evolution 
suggesting an important biological function. However, the affinity for CTS varies 
between species but also among the different isoforms of the α subunit for 
unknown reasons. All human α isoforms are sensitive to CTS and have similar Kd 
values in nM range while in, for example mouse and rat, only isoforms α2-α4 are 
sensitive whereas α 1 is insensitive to ouabain (Crambert et al., 2000). Data has 
demonstrated that two amino acids alterations in position 111 and 122 are 
responsible for the insensitivity for ouabain in mouse and rat α1 isoform (Price and 
Lingrel, 1988). 
 
Elevated levels of endogenous ouabain have been found in animals and humans due 
to physical exercise (Bauer et al., 2005; Goto et al., 1995) and in vitro studies have 
shown that secretion of ouabain from the adrenal cortex is stimulated through 
angiotensin II, phenylephrine and vasopressin (Laredo et al., 1997; Shah et al., 1999).  
 
It has been questioned if endogenous ouabain acts as a natriuretic hormone 
however it does not fulfill all criteria’s even if it is involved in both sodium loading 
and depletion. There are studies with conflicting results both disagreeing and 
promoting ouabain’s role in the regulation mechanism of blood pressure. Ho et al. 
and Butt et al. have both showed that intake of salt will stimulate ouabain secretion 
in rats (Butt et al., 1997; Ho et al., 1997). In contrast Manunta et al. showed that salt 
intake over 2 weeks did not affect the plasma levels of ouabain in a group of patient 
with untreated hypertension. However 2 weeks with salt depletion did increase 
ouabain levels. (Manunta et al., 2001). Balzan et al has also reported that ouabain 
levels are not altered due to salt intake (Balzan et al., 2005). They have also reported 
that ACTH is a possible factor able to modulate ouabain secretion during 
hypertension. Furthermore elevated levels of ouabain has been reported under 
ACTH-induced hypertension (Goto et al., 1996). Prolonged administration of ouabain 
in two groups of mice, one expressing an ouabain-insensitive α2 isoform in the 
sodium pump and the other expressing an ouabain sensitive α2 isoform, showed 
increased levels of ouabain in both groups but only the group with the ouabain-
sensitive α2 isoform developed high blood pressure, suggesting a role for ouabain in 
blood pressure (Dostanic et al., 2005). The cardiotonic steroid-binding site of the α2 
isoform also plays a role in maintaining normal systolic blood pressure during 
pregnancy (Oshiro et al.). 
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1.5.1.4. Signal transduction 
More recently it has been established that the sodium pump in addition to be an 
energy-transducing ion pump can transmit signals and activate different intracellular 
pathways. However, it is when the CTS concentration are so low that it is insufficient 
to inhibit the pump and alter intracellular Na+ and K+ concentrations that CTS will 
contribute to signal transduction via activation of intracellular signaling pathways.  
 
Xie and coworkers have, in a series of publications (Xie, 2001; Xie and Askari, 2002; 
Xie and Cai, 2003; Xie and Xie, 2005; Zhang et al., 2008), shown that Src, a small 
membrane-associated non-receptor tyrosine kinase, interacts with the sodium pump 
in the caveolae (Tian et al., 2006; Wang et al., 2004). Binding of ouabain to the 
sodium pump furthermore activates Src which results in tyrosine phosphorylation of 
multiple effectors and thereby initiates different signaling. This also includes 
transactivation of epidermal growth factor receptor (EGFR) (Haas et al., 2002).  
 
Further downstream events of the sodium pump mediated signal transduction can 
be i) recruitment of the adoptor protein Shc that will activate the 
Grb/Ras/Raf/MEK/ERK pathway (Haas et al., 2000) ii) activation of PLC that will 
result in production of InsP3 and DAG (Puceat and Vassort, 1996) or iii) 
mitochondrial production of ROS (Xie et al., 1999).  
 
Moreover it has been established that binding of ouabain to the sodium pump 
activates slow Ca2+ oscillations which further cause activation of the transcription 
factor NF-κB in renal epithelial cells (Aizman et al., 2001). Later it was shown that the 
sodium pump interacts with the InsP3R forming a microdomain. Binding of ouabain 
to the sodium pump affected this interaction by altering the conformation of the 
pump which results in the Ca2+ oscillations (Miyakawa-Naito et al., 2003). Further it 
has been demonstrated that the interaction between the sodium pump and the 
InsP3R occurs in the N-terminal part of both proteins and that the adaptor protein 
ankyrin-B also interacts in the same region (Chen et al., 2008; Kline et al., 2008; Liu 
et al., 2008). The ouabain induced Ca2+ oscillations have also been shown to be 
involved in the rescue of cells from serum-deprivation-induced apoptosis (Li et al., 
2006). 
 
In summary the great diversity in function of the sodium pump is partially a result of 
the wide variety of isoforms for the subunits and partially a result of that the 
interaction between CTS and it binding site in the sodium pump can result in diverse 
functions depending on the concentration of the CST (Figure 5.).  
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Figure 5. Schematic draft over two pathways mediated by  
ouabain and the sodium pump 
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1.5.2. Hyperpolarization-activated cyclic nucleotide-gated channels 
1.5.2.1. Hyperpolarization-activated cyclic nucleotide-gated channels 
Rhythmic electrical activity is found both in the heart and the nervous system. In the 
heart this electrical activity is an inward current of cations If (f=funny current) seen 
in “pacemaker” cells which controls the commencement and modulation of the 
heart beat. In distinct types of neurons a similar current has been identified; Ih 
(h=hyperpolarization current). This current is mainly involved in the regulation of the 
rhythmic activity in the neuronal circuit but also in other processes such as: 
regulation of the resting membrane potential, synaptic transmission, neuronal 
development including dendritic integration and controlling spontaneous Ca2+ 
oscillations and processing of temporal signals (Biel et al., 2009; Craven and Zagotta, 
2006). The responsible actor for those currents has been identified as 
hyperpolarization-activated cyclic nucleotide-gated (HCN) channels and are 
members of the voltage-gated cation channel superfamily (Jackson et al., 2007). 
 
1.5.2.2. Structure 
The HCN channels are build up of six trans-membrane helical segments (S1-S6) 
including a positively charged segment (S4) acting as voltage sensor (Chen et al., 
2000), an ion conducting pore (between S5 and S6) (Jackson et al., 2007) and finally 
a c-terminal α-helical linker region that joins the trans-membrane region to a highly 
evolutionary conserved cyclic nucleotide binding domain (CNBD) (Figure 6.) (Biel et 
al., 2002; Zagotta et al., 2003). The C-linker-CNBD is an autoinhibitory domain that in 
the absence of cAMP reduces the opening probability of the channel (Biel et al., 
2009). Each HCN channel consists of homo- or heterotetramers arranged so the ion 
conducting pore will be located in the central part of the channel (Biel et al., 2009; 
Craven and Zagotta, 2006).  
 
In mammals there exist four different HCN channel subunits, HCN channel 1 – 4. 
They are normally expressed in the heart and the nervous system but the expression 
pattern among the different subunits differs. Generally HCN channel 1, 2 and 4 are 
found in brain and heart while HCN channel 3 is mainly found in neurons (Ishii et al., 
1999; Ludwig et al., 1998; Santoro et al., 1998).  
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Figure 6. Structure of the HCN channel 
 
1.5.2.3. Basic biophysical properties 
HCN channels present specific biophysical characteristics: 
1. Channel activation by membrane hyperpolarization.  
2. Channel activation is facilitated by direct interaction of cyclic nucleotides to 
the CNBD.  
3. Permeable to Na+ and K+ 
4. Channel inactivation by Cs+  1.5.2.3.1 Hyperpolarization 
The HCN channels are activated by membrane hyperpolarization. The V0.5 values 
(membrane voltage at 50 % of maximal charge movement) as well as the activation 
kinetics for voltage-dependent activation differ among the four HCN channels. For 
example the HCN channel 1 has the fastest kinetics whereas HCN channel 4 has the 
slowest properties (Biel et al., 2009). 
 1.5.2.3.2. Cyclic nucleotides 
An elevated level of cAMP facilitates activation of the channel by shifting the V0.5 
value towards a more positive value and thereby accelerates the opening kinetic of 
the channel. Consequently high concentration of cellular cAMP will result in a 
channel opening that is faster and more complete compared to that at low cAMP 
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concentration. Thus is the cAMP regulation of HCN channels of great importance 
when it comes to physiological mechanisms since the channel are responsible for 
the electrical (e.g. membrane potential) and chemical (e.g. neurotransmitter and 
hormones) contribution. cGMP are equivalent in function to cAMP although the 
affinity is different and a 10 fold higher concentration of cGMP is needed to receive 
the same effect in shifting the potential towards a more depolarized voltage as for 
cAMP (Biel et al., 2009; Craven and Zagotta, 2006; DiFrancesco and Tortora, 1991; 
Ludwig et al., 1998). 
 
1.5.2.3.3. Permeabilization 
HCN channels are permeable to K+ and Na+ (DiFrancesco, 1993; Ludwig et al., 1998; 
Santoro et al., 1998; Yu et al., 1995). They are slightly more selective for K+ over Na+ 
(ration 4:1) which will result in an inward ion current of Na+ that will depolarize the 
membrane toward the threshold to trigger an action potential due to activation of 
the channel at resting membrane potential (around -70 mV) (Craven and Zagotta, 
2006). 
 
In addition to K+ and Na+ two of the channels, HCN channel 2 and 4, are also 
permeable to Ca2+ (Michels et al., 2008; Yu et al., 2004). The physiological 
implication of Ca2+ signaling through these channels has not been clear. However a 
role for the HCN channel 2 in apoptosis signaling was recently suggested. Kinase 
inhibitors (staurosporine and PKC412) can causes a Ca2+ influx through the HCN 
channel 2 through phosphorylation of Thr549 within the internal regulatory domain 
of the channel. The imported Ca2+ then triggers apoptosis mediated by calpain and 
AIF (Norberg et al., 2010a).  
 1.5.2.3.5. Inactivation  
One other characteristic of those channels include a pharmacological outline 
showing inactivation of the channels with milimolar concentration of Cs+ although 
they are unaffected of Ba2+ (Biel et al., 2009; Craven and Zagotta, 2006). 
 
1.5.2.4. Further regulations mechanisms of the channels 
Wu and Cohen suggested in late the 1990’s that HCN channels can be regulated 
through tyrosine kinases from the Src family (Wu and Cohen, 1997). Their founding 
was supported by mapping experiments that demonstrated that Src actually binds to 
the C-linker-CNBD in HCN channel 2 via its SH3 domain and thereby phosphorylates 
the channel (Zong et al., 2005). A consequence of this phosphorylation is accelerated 
channel activation. It has been further demonstrated that HCN channels can be 
regulated by tyrosine phosphorylation via Src kinases under physiological conditions 
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in pacemaker cells in the sinoatrial node in mice and rat heart as well as in neurons 
(Biel et al., 2009). 
 
Another regulation mechanism of the HCN channels is via p38-mitogen-activated 
protein (MAP) kinases. If the activation occurs directly via phosphorylation the 
channel or indirectly via phosphorylation of another protein interacting with the 
channel is not established (Poolos et al., 2006). Different experiments have 
demonstrated that activation via p38-MAP kinase in hippocampal pyramidal neurons 
shifts the voltage dependent activation potential in the direction of a more positive 
value and thereby influences neuronal excitability and temporal summation (the 
way in which non-simultaneous synaptic events combine in time) (Biel et al., 2009). 
 
1.5.2.5. Pathology  
HCN channels are expressed in the nervous system and heart and channel defects 
have been related with diseases such as epilepsy, neuropathic peripheral pain and 
cardiac arrhythmia. Cardiac hypertrophy and heart failure are consequences of 
upregulated If as a result of enhanced expression of HCN channels. It has been 
shown that upregulated If results in ectopic pacemaker like patterns in the 
ventricular muscle that can lead to arrhythmia and heart failure (Biel et al., 2009).  
 
 
  
 31 
 
2  Aims 
The different projects in this thesis investigated the role of Ca2+ in different 
developmental and disease processes. Further defined aims were: 
 
1. Examine the impact of Ca2+ and Na+, K+-ATPase signaling in dendritic growth 
in cortical neurons 
 
2.  Characterize the mechanism behind the prolonged Ca2+ increase following 
treatment with PKC inhibitors (staurosporine and PKC412). 
 
3. To investigate how Ca2+ homeostasis was affected by BCG in human bladder 
cancer (T24) cells and to look at downstream targets.  
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3  Results and discussion  
3.1 Paper I – Na+, K+-ATPase signal transduction triggers CREB 
activation and dendritic growth 
Neuronal cells are characterized by dendrites that form the complex signaling 
network for different functions in the brain. The growth of dendrites includes a 
dynamic process taking place during neurogenesis accomplice by a variety of factors.  
 
3.1.1. Na+, K+-ATPase receptor activation triggers dendritic growth in 
cortical neurons 
To investigate the impact of Na+, K+-ATPase or the sodium pump on dendritic growth 
primary cultures of rat cortical neurons were stimulated with 1 µM ouabain for 48 
hours. Received data showed an enhanced dendritic growth with respect to both 
length and number compared with the mock treatment. The dendritic lengths were 
nearly 2-fold increased and the number of dendrites improved by almost 100 %.  
 
3.1.2. Na+, K+-ATPase signal transduction occurs without changing the 
resting membrane potential 
Next 86Rb+ uptake experiments were performed to rule out the inhibitory effect of 
ouabain on the Na+, K+-ATPase. These data showed that 1 µM ouabain only inhibited 
the pump by 20.7 ± 4.6 % and that the IC50 for cortical neuron Na, K-ATPase was 13.2 
µM for ouabain. These findings suggest that the Na+, K+-ATPase conveys the effect 
due to signal transduction rather than pump inhibition. Since Na+, K+-ATPase primary 
role is to establish the electrochemical gradient in cells (Kaplan JH 2002), ouabain’s 
effect on the resting membrane potential was examined by whole-cell patch clamp 
recordings. Ouabain 1 µM did not have any significant effect on the resting 
membrane potential while ouabain 100 µM depolarized the membrane. However, 
ouabain 100 µM had no effect on dendritic growth so membrane depolarization 
alone was not sufficient to trigger dendritic growth. These results indicate that the 
concentration of ouabain used (1 µM) neither inhibits the pump nor depolarizes the 
cells.  
 
In addition Ca2+ oscillations were observed following ouabain treatment for 6 hours. 
Furthermore the L-type Ca2+ blocker nifidepine inhibited the Ca2+ response.  
 
3.1.3. MAP kinase phosphorylation is stimulated by Na+, K+-ATPase 
signaling 
MAP kinases are serine/threonine-specific protein kinases that have been shown to 
be involved in the regulation of dendritic growth and determination of neuronal 
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morphology. To look at the involvement of MAP kinases in Na+, K+-ATPase signal 
transduction phosphorylation of ERK 1/2 (p42/44 MAP kinase) was monitored by 
Western blotting. Cortical neurons stimulated with ouabain for 6 hours showed a 
sustained ERK 1/2 phosphorylation. This phosphorylation was eliminated by the 
upstream MEK inhibitor U0126. To investigate the effect of Ca2+ on ERK 1/2 
phosphorylation cells were pre-incubated with nifedipine, which reduced the 
phosphorylation level. The ERK 1/2 phosphorylation was furthermore partially 
abolished by the CaM kinase inhibitor KN93.  
 
3.1.4. Na+, K+-ATPase signal transduction triggers CREB transcription 
through CaM kinases 
One transcription factor implicated in neuronal differentiation which is regulated via 
CaM kinase is CREB. To study the involvement of CREB immunocytochemistry 
experiments were performed. Six hours ouabain treatment showed increased levels 
of Ser-133 phosphorylated CREB. These results were further supported by Western 
blot. Next the pathways involved in the Na+, K+-ATPase signal transduced CREB 
phosphorylation was further examined. The MEK inhibitor U0126, CaM kinase 
inhibitor KN93 and L-type Ca2+ blocker all reduced the levels of Ser-133 
phosphorylated CREB. Even if phosphorylation of Ser-133 is required for CREB-
dependent transcription it is not adequate for gene activation (Wayman et al 2006). 
To resolve this problem a CRE-luciferase assay was done. These data showed a 3 fold 
increase in CRE activity after 6 hours treatment with ouabain and the CRE activity 
were totally abolished by KN93.  
 
3.1.5. Dendritic growth induced by Na+, K+-ATPase signaling is 
orchestrated by MAP kinases, CaM kinases and extracellular Ca2+ influx 
Finally, the involvement of Ca2+, MAP kinases and CaM kinases on Na+, K+-ATPase 
signal-transduction induced dendritic growth was investigated. The Ca2+ inhibitor 
nifedipine and the MEK inhibitor U0126 both significantly decreased the neurite 
outgrowth while the CaM kinase inhibitor KN93 completely abrogates the 
outgrowth.  
 
3.1.6. Conclusion 
In this study we demonstrated that Na+, K+-ATPase signal transduction is able to 
stimulate dendritic growth in cortical neurons from rat. This biological process 
activates a transcriptional program involving activation of CREB and CRE regulated 
via the CaM kinase pathway, sustained MAP kinase phosphorylation and 
intracellular Ca2+ oscillations (Figure 7). These findings suggest a novel role for Na+, 
K+-ATPase as a modulator of dendritogenesis in developing cortical neurons in the 
brain and that it therefore might play an important role in circuit wiring. 
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Figure 7. Schematic draft over Na+, K+-ATPase signal  
transduction and dendritic growth  
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3.2 Paper II – Critical role for hyperpolarization-activated cyclic 
nucleotide-gated channel 2 in the AIF-mediated apoptosis 
Non-small-cell lung carcinomas (NSCLC) are resistant to conventional cancer 
therapy. However, the protein kinase C (PKC) inhibitors staurosporine (STS) and 
PKC412 are both able to trigger cell death in those cells (Josephs et al. 2002, Gallego 
et al. 2004). It has been previously reported that these PKC inhibitors induces cell 
death through a prolonged elevation in the intracellular Ca2+ from the extracellular 
milieu (Norberg et al. 2008).  
 
3.2.1. PKC inhibitor induced Ca2+ influx occurs via hyperpolarized-activated cyclic 
nucleotide-gated channel 2 in NSCLC cells  
To further investigate the involvement of Ca2+ and which channels that might be 
responsible for the Ca2+ elevation, different antagonists of the voltage-dependent 
Ca2+ channels (VDCCs) was tested but none had any effect on the Ca2+ influx. Most 
VDCC are activated by depolarization and only a few by hyperpolarization 
(Siegelbaum et al 2000). Thus, STS and PKC412 ability to affect the membrane 
potential was examined. Unexpectedly a hyperpolarization of the cells was detected 
with both STS and PKC412.  
 
As mentioned before only a few plasma membrane channels are activated by 
hyperpolarization. The criteria that they also need to be permeable for Ca2+ make 
the list of choice even shorter. Interestingly, a family of hyperpolarization-activated 
cyclic nucleotide-gated (HCN) channels are activated by hyperpolarization and two 
of four channels, HCN channel 2 and 4, are furthermore permeable to Ca2+ in 
addition to K+ and Na+ (Yu et al. 2004, Michels et al 2008). 
 
Therefore, the possibility of involvement of HCN channels was further studied. Cells 
were treated with Cs+ before exposure of STS or PKC412 meanwhile recording the 
membrane potential and Ca2+ levels. Cs+ treatment was shown to inhibit both the 
hyperpolarization and the Ca2+ elevations. Suggesting that hyperpolarization is 
required for the Ca2+ influx, and that this most probably occurs through the HCN 
channels. 
 
Next the expression levels of HCN channel 2 and 4 in U1810 and H661 cells was 
investigated. mRNA expression was noted for both HCN channel 2 and 4 while 
protein expression only was detected for HCN channel 2. To further investigate the 
potential role of HCN channels in the Ca2+ influx, HCN channel 2 and HCN channel 4 
was downregulated by siRNA and intracellular Ca2+ levels was recorded while 
exposing the cells for STS or PKC412. Interestingly, downregulation of HCN channel 2 
but not HCN channel 4 was shown to eliminate the STS/PKC412 induced Ca2+ influx.  
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3.2.2. Ca2+influx through HCN channel 2 leads to AIF-mediated cell death  
Previously STS and PKC412 have been shown to induce elevated levels of 
intracellular Ca2+ that can trigger apoptosis in NLCSC cells (Norberg et al. 2008). So 
next, it was investigated if the STS/PKC412 induced Ca2+ influx via HCN channel 2 
was adequate to trigger apoptosis in this case. These results showed that the Ca2+ 
entry through HCN2 is sufficient to induce apoptosis.  
 
The mechanism that triggers cell death was additional examined. Cleavage of Atg5 
and AIF (two selective calpain substrates) was monitored in control cells but were 
suppressed in cells with downregulated HCN channel 2. These results were 
supported by flow cytometry analysis of Annexin V staining, counting of condensed 
nuclei, processing/activation of caspase-2,-3,-8,-9 and monitoring of PARP cleavage 
and finally caspase-3, -like activity measurements. All demonstrating that HCN 
channel 2 induced Ca2+ influx triggers a caspase-independent, AIF-mediated 
apoptosis.  
 
Another cell line, HEK29, which normally lacks the HCN channels, is therefore 
commonly used as a model system to study the heterologus HCN channel expression 
(Yu et al 2004). It was shown that stimulation with STS/PKC412 could not as 
expected induce a Ca2+ influx in those cells. However, after introducing the HCN 
channel 2 channel into the cells a prolonged Ca2+ influx could be monitored. Similar 
to earlier results, AIF was released from the mitochondria due to STS exposure, only 
in cells expressing HCN channel 2. Flow cytometry analysis with Annexin V staining 
demonstrated that HEK293 cells survived STS/PKC412 treatment at least 24 h while 
expression of HCN2 sensitized the cells to the STS/PKC412 treatment. These data 
demonstrated that HCN2 was indeed responsible for cellular Ca2+ influx after 
treatment with PKC inhibitors. 
 
3.2.3. Dephosporylation of THr549 is fundamental for the STS/PKC412 induced 
Ca2+ influx through HCN channel 2 
cAMP and phosphorylation are two critical events for opening the HCN channels 
(Zong et al 2003, Biel et al 2009). To further look at the phosphorylation mechanism, 
cells were exposed to two PKC activators before stimulated with STS/PKC412. The 
results here showed that the PKC activators instead of giving a prolonged Ca2+ 
elevation gave a fast Ca2+ peak. However, Norberg et al 2008 have shown that this 
short Ca2+ peak is inadequate to trigger apoptosis.  
 
Analysis of the Ser/Thr phosphorylation level of the HCN channel 2 in open/closed 
states showed increased phosphorylation in control cells while STS exposure 
dephosphorylated the channel while the PKC activators were able to suppress this 
decrease.  
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In silico analysis of the HCN channel 2 exposed four PKC phosphorylation sites within 
the internal C-terminal domain of the channel. Alignment showed that these 
phosphorylation sites are conserved between human and mouse. Thereafter site-
directed mutagenesis of the four phosphorylation sites where Ser/Thr was 
substituted to an Ala was performed. The mutants showed a similar Ca2+ response to 
STS/PKC412 as the wild-type (non-mutated).  
 
As previously described STS/PKC412 triggers activation of the HCN channel 2 via 
hyperpolarization and dephosphorylation. Therefore, the Ala might be opened by 
the same mechanism or due to the hyperpolarization. Experiments with reduced 
levels of K+ showed a hyperpolarization in the wild-type as well in all mutants while a 
prolonged Ca2+ response only were observed with the Thr549 mutant. Proposing that 
dephosporylation of the residue Thr549 is crucial for the prolonged Ca2+ response.  
 
3.2.4. STS/PKC412 induces a prolonged Ca2+ influx via HCN channel 2 also in 
cortical neurons 
In vivo data proposed that the AIF-mediated pathway might be critical for neuronal 
cell death (Zhu et al 2007a, 2007b, Hangen et al 2010). Therefore, it was investigated 
if a similar mechanism seen in carcinoma lung cells was also observed in primary 
cultures from rat cortex. Both STS and PKC293 induced a Ca2+ influx which was 
abolished by Cs+ and depletion of HCN2. HCN2 depletion also prevented the AIF 
processing as well as suppressed the amount of condensed nuclei.  
 
3.2.5. Conclusions 
Here we have showed that the PKC inhibitors STS and PKC412 both can trigger a Ca2+ 
influx through the HCN channel 2 is adequate to trigger AIF-mediated apoptosis in 
lung carcinoma cells and primary culture of cortical neurons (Figure 8.). 
Furthermore, down-regulation of the HCN channel 2 prevented the Ca2+ influx and 
the following apoptosis. In HEK293 cells, not expressing the HCN channels the PKC 
inhibitors did not cause any Ca2+ influx or apoptosis. However, expression of HCN 
channel 2 sensitized them to STS/PKC412 induced apoptosis. Finally, mutagenesis of 
PKC phosphorylation sites at the C-terminal domain of the HCN2 revealed that 
dephosporylation of Thr549 was critical for the Ca2+ influx required for AIF-mediated 
apoptosis. These results demonstrate a novel role of the HCN channel 2 as an 
upstream regulator of cell death triggered by PKC inhibitors. This finding might have 
an important role in the treatment of NSCLC. Since the HCN channel 2 is a potential 
drug target the expression pattern of HCN channel 2 will be analyzed in patient 
samples.  
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Figure 8. Schematic cartoon over STS/PKC412 induced AIF apoptosis 
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3.3 Paper III – Bacillus Calmette-Guerin (BCG) Stops Urinary Bladder 
Cancer Cell Proliferation through PLCβ3-Dependent Ca2+ Signaling 
Bladder cancer refers to malignant growth in the urinary bladder. 70-80 % of bladder 
cancer is non-muscle invasive cancer (Simons et al., 2008). The initial treatment for 
this type of cancer is transurethral resection (TUR) followed by immunotherapy with 
Bacillus Calmette-Guerin (BCG). BCG triggers an immune response that recruits 
different immune and inflammatory cells and elevated level of chemokines and 
cytokines in the bladder. However the exact mechanism is not fully established.  
 
3.3.1. BCG induces an intracellular Ca2+ response in human urinary bladder cells 
Our main purpose was to examine a more direct effect of BCG on cancer cells. To 
investigate how Ca2+ homeostasis was affected by BCG, human bladder cancer cells 
(T24) were loaded with the Ca2+ sensitive fluorescent dye Fluo-3/AM. Those 
experiments showed a Ca2+ response (including oscillations, transients and sustained 
Ca2+ responses) in both presence and absence of extracellular Ca2+ indicating an 
intracellular source of Ca2+. Furthermore, addition of peptidoglycan (PGN) (a 
polymer from the bacterial cell wall) to the cells triggered a Ca2+ response similar to 
the one from BCG.  
 
The intracellular localization of internalized BCG was studied by using BacLight 
stained BCG, a bacterial dye staining the bacterial membrane, which were 
monitored using confocal microscopy. Double-staining with ER-tracker suggest a co-
localization between BCG and ER. After internalization of BCG to the cell it might 
interact with ER but this needs further investigations.  
 
3.3.2. PLC is affecting BCG induced Ca2+ singling 
Next pharmacological studies were performed to investigate downstream targets of 
BCG. Pretreatment with Cyclopiazonic acid (CPA), an inhibitor of the 
sarcoplasmic/endoplasmic reticulum calcium (SERCA) pump, reduced the Ca2+ 
response triggered by BCG. These data support the proposal that internal stores 
represent one Ca2+ source in this pathway. The G-protein coupled receptor 
inactivator Pertussis toxin (PTX) also suppressed the Ca2+ increased.  
 
One pathway of generating intracellular Ca2+ release is via PLC which processes PIP2 
to InsP3 and diacylglycerol (DAG). InsP3 in turn stimulates Ca2+ release via InsP3R. 
U73122 and ET-18-OCH3, two PLC inhibitors, significantly suppressed the Ca2+ 
response; however U73122’s inactive analogue had no effect. siRNA experiments 
supported the involvement of PLC and knockdown of PLCβ3 but not PLCγ 
suppressed the BCG induced Ca2+ response.  
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3.3.3. The supernatant of BCG also stimulates Ca2+ singling 
The BCG introduced into the bladder is a diverse solution containing the whole 
bacteria plus bacterial fragments from external cell wall, intracellular content, as 
well as smaller particles secreted from the bacteria itself. To look at smaller 
molecules/particles the supernatant of BCG (sBCG) (the supernatant from BCG 
centrifuged for 3 min at 14 000 rpm) was tested on bladder cancer cells. The Ca2+ 
response after sBCG stimulation resembled the one seen with BCG with the 
distinction of fewer oscillating cells. Pretreatment with PTX, U73122 and ET-18-OCH3 
following sBCG stimulation all suppressed the Ca2+ response.  
 
3.3.4. BCG PLC-dependently affects cell proliferation 
Uncontrolled proliferation is one of the hallmarks of cancer therefore BCG’s effect 
on proliferation next was investigated using immunocytochemistry with Ki67 and 
EdU. Ki67 is present in nucleus of cells in all active cell cycle states (G1, S, G2 and M) 
but is absence in resting cells (G0), while EdU detects cells only in the s-phase of the 
cell cycle. These data demonstrated that treatment with BCG independently ofPLB-
985 (DSMO-differentiated human promyelotic leukemia cells to mature neutrophil-
like cells) decreased the amount of EdU positive cells but had no effect on Ki67 
expression. BCG treated cells still seems to remain in the cell cycle but fewer cells 
reached the s-phase. However treatment with the PLC inhibitor U73122 reversed 
the BCG effect on EdU.  
 
3.3.5. Conclusions 
Here we showed that treatment of urinary bladder cancer (T24) cells with BCG 
induces an intracellular Ca2+ increase and reduce cell proliferation. Experiments with 
external Ca2+ free media gave a similar response as presence of extracellular Ca2+ 
indicating a Ca2+ release from internal stores. This was supported through depletion 
of the ER with cyclopiazonic acid (CPA) which blocked the BCG-induced Ca2+ 
response. Furthermore pharmacological block with U73122 or ET-18-OCH3 or 
knockdown with small interference RNA for PLCβ3 repressed Ca2+ signaling and 
U73122 reversed the BCG induced effect seen on cell proliferation (Figure 9.). 
Inhibition with the G-protein receptor blocker pertussis toxin also blocked the 
observed effect. This finding suggests a role for PLC-dependent Ca2+ signaling in cell 
growth of urinary bladder cancer.  
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Figure 9. Schematic sketch over BCG signaling  
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4  General conclusions 
This thesis presents three different studies showing three different roles for Ca2+ 
signaling of crucial importance to cell differentiation, cell proliferation, and cell 
death, three aspects highly coordinated with development and disease.  
 
Paper I. We have demonstrated that ouabain, an endogenous steroid hormone, 
through binding to its receptor Na+, K+-ATPase can trigger dendritic outgrowth in 
cortical neurons. This occurs via a Ca2+ dependent transcriptional program including 
CaM kinases which regulates downstream CREB and CRE mediated gene expression. 
In addition this mechanism also includes Ca2+ oscillations and phosphorylation of 
MAP kinases. These data represents a new role for the Na+, K+-ATPase in dendritic 
growth.  
 
Paper II. A novel role for the Ca2+ permeable HCN channel 2 as an upstream 
regulator of cell death has been shown. This is mediated through a prolonged Ca2+ 
elevation which leads to calpain activation and processing of AIF. AIF will be released 
from the mitochondria to the cytoplasm and translocates to the nucleus where is 
induces chromatin condensation. 
 
Paper III. We showed that BCG triggers a PLC-dependent Ca2+ response in human 
bladder cancer cells that reduce cell proliferation and thereby cancer cell growth. 
Store depletion by SERCA inhibition blocked the BCG-triggered signal cascade 
suggesting a role of ER as a Ca2+ source. However, this signaling event was 
dependent on PLC since pharmacological inhibition or small interference RNA-
mediated gene silencing abolished the response. Finally EdU incorporation showed 
that BCG-controlled cell proliferation was mediated via a Ca2+- and PLC-dependent 
mechanism.  
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Dendritic growth is pivotal in the neurogenesis of cortical neurons.
The sodium pump, or Na,K-ATPase, is an evolutionarily conserved
protein that, in addition to its central role in establishing the
electrochemical gradient, has recently been reported to function as
a receptor and signaling mediator. Although a large body of
evidence points toward a dual function for the Na,K-ATPase, few
biological implications of this signaling pathway have been de-
scribed. Here we report that Na,K-ATPase signal transduction
triggers dendritic growth as well as a transcriptional program
dependent on cAMP response element binding protein (CREB) and
cAMP response element (CRE)-mediated gene expression, primarily
regulated via Ca2/calmodulin-dependent protein (CaM) kinases.
The signaling cascade mediating dendritic arbor growth also in-
volves intracellular Ca2 oscillations and sustained phosphoryla-
tion of mitogen-activated protein (MAP) kinases. Thus, our results
suggest a novel role for the Na,K-ATPase as a modulator of
dendritic growth in developing neurons.
Calcium signaling  CREB  Dendritic growth  Na,K-ATPase signaling 
Neuronal development
Dendrites characterize neuronal cells from other cell typesand allow neurons to form networks that are responsible for
different functions in the brain. The growth of dendrites is a
highly dynamic process that involves a series of orchestrated
signaling events that take place during neurogenesis (1–3). In the
developing cortex, several phenomena and signaling mecha-
nisms have been demonstrated, including layer-specific dendritic
growth and branching activated by neurotrophins (4), restricted
dendritic growth via Notch1 signaling (5), and dendritic devel-
opment via intracellular calcium (Ca2) signaling (6).
The sodium pump, or Na,K-ATPase, belongs to a family of
evolutionarily ancient enzymes that catalyze active transport of
cations through hydrolysis of adenosine triphosphate (ATP)
across the cell membrane in all mammalian cells (7). In the
central nervous system, mutations in Na,K-ATPase are known to
cause neuronal dysfunction and neurodegeneration in Drosoph-
ila (8), familial hemiplegic migraine in humans (9), and rapid-
onset dystonia-Parkinsonism (10). In addition tomaintaining the
electrochemical gradient, the Na,K-ATPase has been shown to
act as a receptor and signal transducer. Previous reports indicate
that Na,K-ATPase signal transduction stimulates proliferation in
smooth muscle cells (11) and apoptosis in prostate cancer cells
(12). Ouabain, an endogenously synthesized hormone (13, 14),
is Na,K-ATPase’s ligand and forms a hormone-receptor com-
plex capable of inducing mitogen-activated protein (MAP)
kinase phosphorylation (15, 16) and intracellular Ca2 signal-
ing (17–19).
In developing neurons, Ca2 signaling has been shown to
control proliferation, differentiation, and dendritic growth (6,
20–22) by acting on MAP kinases (23, 24) and Ca2/calmodu-
lin-dependent protein kinases (CaM kinases) (25, 26). Both of
these kinases are known to control the transcription factor
cAMP response element binding protein (CREB), which regu-
lates cell proliferation and differentiation in a range of cell types
in developing vertebrates (27–29). Because the CREB-activating
pathways can also be triggered by Na,K-ATPase signaling, we
investigated whether the Na,K-ATPase is involved in neuronal
differentiation.
We report here that signal transduction activated by the
Na,K-ATPase indeed modulates dendritogenesis in developing
cortical neurons. This biological process involves a transcrip-
tional program dependent on CREB-mediated and cAMP re-
sponse element (CRE)-mediated gene expression via CaM
kinases as well as MAP kinase phosphorylation and intracellular
Ca2 signaling. These data provide evidence for a novel signaling
pathway by which the Na,K-ATPase stimulate dendritic growth
in the developing brain and may thus play an important role in
circuits wiring.
Results
Na,K-ATPase Receptor Activation Triggers Dendritic Growth in Corti-
cal Neurons. The effect of Na,K-ATPase signal transduction on
dendritic growth was studied in cortical neurons prepared from
embryonic day (E) 18 rats. To visualize dendritic morphology of
individual cells we immunolabeled cortical neurons with a
MAP2 antibody at E18  4 days in vitro (DIV). This approach
reveals the detailed dendritic morphology of cortical neurons in
primary culture and can be applied to study the role of diverse
signaling pathways in regulating dendritic growth (30). Neurons
exposed to the steroid hormone ouabain (1 mol/l) for 48 hours
showed distinctive morphological changes observed as signifi-
cantly enhanced dendritic growth (Figs. 1A and 1B). The effect
of ouabain on Na,K-ATPase varies in a dose-dependent manner
(31, 32); therefore, cortical neurons were exposed to graded
concentrations of ouabain, and dendritic arbor growth was
examined. As shown in Fig. 1C, both the length and number of
dendrites significantly increased when cells were treated with
ouabain concentrations of 0.5 mol/l and 1 mol/l. The dendritic
lengths were extended almost 2-fold and the number of dendrites
increased by 100% after 1 mol/l ouabain for 48 hours
compared with mock treatment. In contrast, ouabain concen-
trations of 10 mol/l or higher did not enhance dendritic growth
in cortical neurons (Fig. 1C). Consequently, the optimal con-
centration for dendritogenesis, 1 mol/l ouabain, was used for all
subsequent experiments.
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Na,K-ATPase Signal Transduction Occurs Without Changing the Rest-
ing Membrane Potential. Ouabain is a well-established catalytic
inhibitor of the Na,K-ATPase. To determine the extent to which
ouabain inhibits Na,K-ATPase activity in cortical neurons, we
carried out 86Rb-f lux experiments. Uptake of 86Rb is corre-
lated with K uptake and thus reflects the turnover rate of the
pump. The results show that cortical neuronal Na,K-ATPase had
an IC50 of 13.2mol/l (95% confidence interval) for ouabain and
that the optimal concentration for dendritic growth, 1 mol/l
ouabain, inhibited active 86Rb uptake only by 20.7 4.8% (n
7) (Fig. 2A). Previous studies have shown that Na,K-ATPase
isoforms have different affinities for ouabain (31) as well as
cell-type-specific and developmental-specific expression pat-
terns (33). The 3- and 2-isoforms of Na,K-ATPase have a
higher affinity to ouabain as compared with the rather insensi-
tive 1-isoform (31, 32). Thus, we determined the identity of the
-subunit isoforms expressed in rat cortical neurons in primary
culture by reverse transcription-polymerase chain reaction (RT-
PCR) using sequence-specific primers. mRNA (cDNA) from three
Na,K-ATPase -subunit isoforms, including the neuron-specific
3-isoform, were detected in rat cortical neurons (Fig. 2B).
To rule out an effect of ouabain on the resting membrane
potential, whole-cell patch-clamp recordings were made from
cortical neurons. Ouabain at a concentration of 1 mol/l or 10
mol/l had no significant effect on the resting membrane
potential of cortical neurons (Figs. 2C and 2D). At a higher
concentration of 100mol/l, at which enzyme activity is inhibited
by 72.2  2.2% (n  7), ouabain depolarized the membrane
potential from 62.2  0.7 mV to 56.1  0.8 mV (n  12)
(Figs. 2C and 2D). These results demonstrate that ouabain does
not alter the resting membrane potential at concentrations that
promote dendritogenesis.
Calcium signaling exerts a profound influence on dendritic
growth during development (6). We therefore examined the
effect of Na,K-ATPase signal transduction on Ca2 signaling in
cortical neurons. Intracellular Ca2 dynamics were imaged in
neuronal cells loaded with the Ca2-sensitive fluorescent dye
Fluo-3/AM. When cortical neurons were exposed to 1 mol/l
ouabain for 6 hours, the treatment that elicited a robust effect
on dendritic growth, slow intracellular Ca2 oscillations were
induced (Fig. 2E). Intracellular Ca2 signaling was also observed
in untreated cells, 9.5  0.9% (n  147) but was significantly
increased in neurons treated with ouabain, 40.1  13.8% (n 
129) (Fig. 2F). These Ca2 oscillations were strongly suppressed
by the L-type Ca2 channel blocker nifedipine, 6.7  4.0% (n 
140) (Fig. 2F and [supporting information (SI) Fig. S1A]).
Neither inhibition of MAP kinases by U0126 nor CaM kinases
by KN93 abolished ouabain-induced Ca2 oscillations in cortical
neurons (below and Fig. 2F).
MAP Kinase Phosphorylation Is Stimulated by Na,K-ATPase Signaling.
Activation of MAP kinases plays an important role, largely
through regulation of gene transcription, in a number of cellular
processes including cell proliferation, DNA synthesis, differen-
tiation, and survival (23, 34, 35). In neurons, MAP kinases have
been shown to regulate dendritic growth and morphology (24,
36). To assess whether Na,K-ATPase signal transduction acti-
vates p42/44 MAP kinase (referred to as ERK1/2) in cortical
neurons, we exposed neurons to ouabain andmonitored ERK1/2
phosphorylation using Western blotting. When cells were exam-
ined after 10 minutes of ouabain treatment no ERK1/2 phos-
phorylation was observed (data not shown). Cortical neurons
exposed to ouabain for 4 hours and 6 hours, however, showed a
sustained and significant ERK1/2 phosphorylation, which was
abolished using the selective MEK inhibitor U0126 (Fig. 3A).
Sustained activation of MAP kinases has previously been asso-
Fig. 1. Na,K-ATPase signal transduction triggers dendritic arbor growth in
cortical neurons. (A and B) Confocal images of E18 cortical neurons in culture
at 4 DIV immunolabeled with anti-MAP2 antibody treated with mock (A)
versus 1 mol/l ouabain (B) for 48 hours. Scale bars, 40 m. (C) Quantification
of length and arborization of MAP2-positive dendrites treated with various
concentrations of ouabain, as indicated in the figure. Results are pooled from
10 randomly selected fields of view times three cultures. * P  0.05 versus
mock.
Fig. 2. Na,K-ATPase signaling occurs without changing the resting mem-
brane potential. (A) Effect of ouabain on active 86Rb transport by Na,K-
ATPase. Cortical neurons at E18  4 DIV were incubated for 30 minutes with
indicated concentrations of ouabain. The IC50 for the reduction in 86Rb
transport was 13.2 mol/l ouabain (n  7). (B) Expression of -subunit Na,K-
ATPase isoform-specific mRNA (cDNA) in E18 cortical neurons at 4 DIV. Am-
plification of the GAPDH-specific signal was performed as control. (C) Whole-
cell patch-clamp recording of a cortical neuron at E18 4 DIV stimulatedwith
1, 10, or 100 mol/l ouabain (resting membrane potential, 61 mV). (D)
Quantitative data of the membrane potential in cortical neurons at E18  4
DIV stimulated with 1, 10, or 100 mol/l ouabain. * P  0.05 versus mock. (E)
Representative single-cell Ca2 recording of a Fluo-3/AM-loaded E18 cortical
neuron in culture at 4 DIV treated with ouabain 1 mol/l, 6 hours before
initiating measurements. Ratio F/F0 represents fluorescence intensity over
baseline. (F) Quantification of the percentage of Na,K-ATPase signal-
transduced Ca2 oscillating cells after treatment with the inhibitors nifedi-
pine, U0126, and KN93, respectively. *P  0.05 versus mock.
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ciated with physiological phenomena such as gene transcription
and dendritic growth (34, 37). We then tested whether MEK and
MAP kinases had any effect on the Ca2 oscillatory response
evoked by treating cells with ouabain for 6 hours. U0126 did not
block ouabain-induced Ca2 oscillations (Fig. S1B) and had no
significant effect on the number of responding cells, 31.6 6.9%
(n  118), when compared with ouabain treatment alone (Fig.
2F). To determine the effect of Ca2 signaling induced by
Na,K-ATPase signal transduction on ERK1/2 activation, we next
examined cells preincubated with the Ca2 signaling inhibitor
nifedipine. Cortical neurons exhibited a reduced level of Na,K-
ATPase signal transduced ERK1/2 phosphorylation after nifed-
ipine pretreatment (Fig. 3B).
The family of CaM kinases is a principal downstream target of
Ca2 signaling that is known to regulate neuronal differentiation
and dendritic growth (25, 26, 29). To test whether these kinases
were involved in mediating Na,K-ATPase signal transduction in
cortical neurons, cells were stimulated with ouabain in the
absence or presence of the general CaM kinase inhibitor KN93.
After this treatment, phosphorylation of ERK1/2 was partially,
yet not significantly (P  0.3, one-way analysis of variance
[ANOVA]), inhibited in cortical neurons (Fig. 3C). Next we
investigated whether CaM kinases were involved in the ouabain-
induced Ca2 oscillations. Pretreatment with KN93 did not
abolish Na,K-ATPase signal transduced Ca2 oscillations,
37.7  9.6% (n  134) (Fig. 2F and Fig. S1C). These results
indicate that activation of MAP kinases by Na,K-ATPase signal
transduction involves the synergistic actions of MEK, Ca2
oscillations, and CaM kinases.
Na,K-ATPase Signal Transduction Triggers CREB Transcription Through
CaM Kinases. The transcription factor CREB is implicated in
neuronal differentiation (26, 27), where it is strongly regulated
via CaM kinases (28, 38). To determine the effect of Na,K-
ATPase signal transduction on CREB activation we first carried
out immunocytochemistry experiments using an antibody spe-
cific for Ser-133-phosphorylated CREB. After ouabain treat-
ment for 6 hours, immunostaining revealed a marked increase of
phosphorylated CREB within the nucleus (Fig. 4A). The nuclear
localization of CREB was confirmed by co-labeling cortical
neurons with the nuclear stain TO-PRO3 (Fig. 4A). The role of
Na,K-ATPase signal transduction on CREB activation was
further investigated with Western blot experiments using the
Ser-133 phospho-CREB antibody. These experiments showed
that CREB was strongly Ser-133 phosphorylated by Na,K-
ATPase signal transduction (Fig. 4B).
Next we examined which signaling cascades were involved in
the Na,K-ATPase signal-transduced CREB Ser-133 phosphor-
ylation. Inhibiting MAP kinases using U0126 reduced the im-
muno signal detected by the Ser-133 phospho-CREB antibody
(Fig. 4B). CREB Ser-133 phosphorylation was also downregu-
lated by the CaM kinase blocker KN93 (Fig. 4B). CaM kinases
are activated by Ca2 signaling; consequently, when Ca2 oscil-
lations were blocked with nifedipine, a reduction in the CREB
Ser-133 phosphorylation was observed (Fig. 4B). This set of
experiments suggests that each of these pathways is partially
involved in CREB Ser-133 phosphorylation via Na,K-ATPase
Fig. 3. MAP kinase activation is triggered by Na,K-ATPase signal transduc-
tion. (A-C) Western blot of Na,K-ATPase signal-transduced phosphorylated
42/44 MAP kinase (pERK1/2) in cortical neurons at E18 4 DIV treated with 1
mol/l ouabain for 6 hours plus MAP kinase inhibitor U0126 (A), L-type Ca2
channel blocker nifedipine (B), and CaM kinase inhibitor KN93 (C). Each bar
represents the fold increase of phospho-ERK1/2 relative to mock after nor-
malizingagainst total nonphosphorylatedERK1/2.*P0.05 versusmock; †P
0.05 versus ouabain-treated cells.
Fig. 4. CREB activation induced by Na,K-ATPase signal transduction is me-
diated via CaM kinases. (A) Confocal images of phospho-Ser-133 CREB-
immunostained (green) E18 cortical neurons in culture at 5 DIV treated with
mock (left panel) and with ouabain 1 mol/l (right panel) for 6 hours. Nuclear
staining with TO-PRO3 (blue). (B) Levels of CREB phosphorylation as detected
by phospho-Ser-133 CREB Western blot of cortical neurons at E18  5 DIV
treated with 1 mol/l ouabain for 6 hours, preincubated with MAP kinase
inhibitor U0126, CaM kinase inhibitor KN93, and L-type Ca2 channel blocker
nifedipine (Nif), respectively. (C) CREB-mediated transcription, measured us-
ingaCRE-luciferase reportergenetransfected intoE18corticalneurons inculture
at 3 DIV, of Na,K-ATPase signal transduction in cortical neurons at E18  5 DIV
treated with mock versus 1 mol/l ouabain for 6 hours, preincubated with MAP
kinase inhibitor U0126, CaM kinase inhibitor KN93, and L-type Ca2 channel
blocker nifedipine (Nif), respectively. Each bar represents the fold increase rela-
tive to mock after normalizing against Renilla. *P 0.05 versus mock.
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signal transduction. Although phosphorylation of CREB at
Ser-133 is required for inducing CREB-dependent transcription,
there are instances in which Ser-133 phosphorylation is not
sufficient for target gene activation (28). To further investigate
CREB activation induced by Na,K-ATPase signal transduction,
cortical neurons cells were transfected with a CRE-luciferase
reporter gene that is activated by endogenous CREB. A signif-
icant 3-fold increase in CRE-luciferase activity was observed
when cells were exposed to ouabain for 6 hours (Fig. 4C).
Whereas U0126 and nifedipine resulted in only a marginal
reduction in ouabain-induced CRE-luciferase activity, KN93
completely abolished the CREB activation triggered by Na,K-
ATPase signal transduction (Fig. 4C). Taken together these
results suggest that CREB activation in cortical neurons trig-
gered by Na,K-ATPase signal transduction predominantly oc-
curs through a CaM kinase-dependent mechanism.
Dendritic Growth Induced by Na,K-ATPase Signaling Is Orchestrated
by MAP Kinases, CaM Kinases, and Extracellular Ca2 Influx. Finally,
we examined the impact of Ca2 signaling, MAP kinases, and
CaM kinases on Na,K-ATPase signal-transduced dendritic
growth in cortical neurons. A partial decrease in ouabain-
triggered dendritic length and arborization was observed in
response to nifedipine treatment, suggesting that L-type chan-
nel-mediated Ca2 influx plays a role in dendritic growth (Fig.
5B). Inhibition ofMAP kinase signaling with U0126 significantly
attenuated dendritogenesis in ouabain-treated cells (Fig. 5C).
Although nifedipine and U0126 both significantly decreased
ouabain-induced neurite outgrowth, neither inhibitor was able to
completely abrogate the Na,K-ATPase signal-transduced effects
on dendritic growth and arborization in cortical neurons. Inhi-
bition of CaM kinases with KN93, however, resulted in complete
inhibition of ouabain-induced dendritic branching (Fig. 5D).
These observations support a model in which Na,K-ATPase
signal transduction triggers dendritic growth via a signaling
pathway that involves extracellular Ca2 influx as well as MAP
kinase and CaM kinase-modulated CREB transcription.
Discussion
The findings presented in this report indicate that Na,K-ATPase
signal transduction induces dendritogenesis in cortical neurons
via activation of a transcriptional program that involves CREB-
and CRE-mediated gene expression, primarily through a CaM
kinase-dependent signaling pathway. This signaling event is
induced by exposing cells to a concentration of ouabain that does
not affect the resting membrane potential. Persistent Ca2
oscillations and sustained MAP kinase phosphorylation also
participate in this signaling cascade, as blocking L-type Ca2
channels or MEK suppresses downstream effects.
Ouabain is an endogenous steroid hormone that is present in
mammalian tissues; it has been isolated from hypothalamus (39),
adrenals (40), and human plasma (41). Evidence indicates that
circulating levels of ouabain and ouabain-like factors are ele-
vated during pregnancy and in newborn infants (13, 32), thereby
suggesting a developmental role for this signaling molecule. Our
results, which show that Na,K-ATPase, the receptor of ouabain,
stimulates dendritic growth in rat cortical neurons, support such
a biological function for ouabain. Concentrations of endogenous
ouabain in the embryonic human brain during the course of
development are unknown but are predicted to lie in the
subnanomolar-to-nanomolar range, as previously reported (13,
32). Indeed, nanomolar concentrations of ouabain stimulates
neurite outgrowth in human neuroblastoma cells (Fig. S2).
Furthermore, in the brain, there are multiple Na,K-ATPase
isoforms that each have cell-type-specific and developmental-
specific expression patterns (33, 42) as well as different ouabain
affinities (31, 42). These spatial and temporal expression pat-
terns of Na,K-ATPase isoform remain largely unknown but may
be involved in the development and wiring of the brain. As such,
the extent to which the different -subunit isoforms contribute
to the overall cellular effects of ouabain remain to be elucidated.
The mechanism by which Na,K-ATPase triggers signal trans-
duction remains disputed, with two principal hypotheses being
proposed. One mechanism suggests that partial inhibition of the
Na,K-ATPase leads to an increased intracellular Na concen-
tration that transactivates Na/Ca2-exchangers, which thereby
produce cytosolic Ca2 waves that are sufficient to elicit down-
stream signaling events (18, 43). The other mechanism suggests
that inhibition of Na,K-ATPase pumping activity is not in itself
required for a signaling event to occur; instead, Na,K-ATPase is
proposed to function via a microdomain where ouabain-induced
signaling occurs via physical association of Na,K-ATPase with a
host of binding partners. Na,K-ATPase has been reported to
associate with the inositol 1,4,5-trisphosphate receptor to gen-
erate intracellular Ca2 oscillations (44) and to form a complex
with the epidermal growth factor receptor, leading to MAP
kinase activation (16). Dendritic growth via Na,K-ATPase signal
transduction might be modulated by either or both of these
signaling pathways.
Using electrophysiological recordings it was shown that 1
mol/l ouabain, the optimal concentration for inducing dendri-
togenesis in cortical neurons, apparently does not change the
resting membrane potential. Ouabain at 100 mol/l, a concen-
tration that did not induce dendritic growth, however, did
depolarize the membrane potential. Thus, ouabain-induced de-
polarization alone does not appear to be sufficient to trigger
dendritic growth in cortical neurons. These data, together with
the 86Rb-f lux experiments, suggest that inhibition of Na,K-
ATPase pumping activity per se is not the mechanism responsible
for triggering this biological process. The observation that
Na,K-ATPase signal transduction is not a fast signaling event is
further strengthened by the experiments on Ca2 signaling and
MAP kinases, which both show delayed responses. Persistent
Fig. 5. Dendritic growth in cortical neurons induced by Na,K-ATPase signal
transduction involves crosstalk between Ca2 signaling, MAP kinases, and
CaM kinases. (A-D) Confocal images of E18 cortical neurons at 4 DIV immu-
nolabeled with anti-MAP2 antibody treated with 1 mol/l ouabain (A) to-
gether with L-type Ca2 channel inhibitor nifedipine (Nif) (B), MAP kinase
inhibitorU0126 (C), andCaMkinase inhibitorKN93 (D) for 48hours. Scalebars,
40 m. (E) Quantification of length and arborization of MAP2-positive den-
drites treated with 1 mol/l ouabain together with nifedipine, U0126, and
KN93, respectively. Results are pooled from 10 randomly selected fields of
view times three cultures. *P  0.05 versus mock; †P  0.05 versus ouabain-
treated cells.
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Ca2 oscillations and sustained ERK1/2 phosphorylation were
detected after 6 hours of pretreatment with 1 mol/l ouabain.
Delayed and sustained phosphorylation of MAP kinases has
previously been implicated in neuronal differentiation (45).
These observations indicate that the signaling mechanism by
which dendritic growth is induced in cortical neurons does not
depend on changes in the resting membrane potential but,
rather, involves a slow process that takes hours to activate.
Analysis of Ser-133 phosphorylation of CREB- and CRE-
mediated gene expression in cortical neurons treated with
ouabain gave rise to somewhat disparate results. This might be
caused by the many phosphorylation sites on the CREB protein
that differentially regulate total CREB activity (27, 28, 46). For
example, phosphorylation at Ser-133 increases CREB activity,
whereas Ser-142 phosphorylation inhibits CREB (38). There-
fore we cannot directly correlate Ser-133 phosphorylation of
CREB with CRE-dependent transcription. Phosphorylated
CREB is also known to bind the Ca2-dependent CREB binding
protein (CBP) to form a molecular complex that determines
CRE transcriptional activity (47). The differential ability of CaM
kinases and MAP kinases to activate CBP (48) may be the
molecular distinction that underlies the distinct biological effects
of these kinases. This difference may explain why inhibiting
MAP kinases decreased Ser-133 phosphorylation of CREB but
failed to block CRE activation induced by Na,K-ATPase sig-
naling. Furthermore, CREB activation was previously demon-
strated to occur via an interplay betweenMAP kinases and CaM
kinases, in whichMAP kinases were involved in amore sustained
phosphorylation of CREB whereas the fast onset of CREB
phosphorylation was triggered by CaM kinases (34, 46, 49).
Taken together, our results suggest that Na,K-ATPase receptor
activation leads to CREB activation and dendritic growth via
crosstalk between the MAP kinase and CaM kinase pathways.
Our findings suggest that Na,K-ATPase signal transduction
stimulates dendritic growth in cortical neurons via activation of
a transcriptional program that involves CREB- and CRE-
mediated gene expression. The signaling pathway is primarily
regulated via CaM kinases, but crosstalk with MAP kinase
phosphorylation and Ca2 oscillations also participates in this
event. This type of mechanism may provide a novel basis for
neuronal differentiation through Na,K-ATPase signal transduc-
tion and induction of a specific program of gene expression that
is critical for the developing nervous system.
Materials and Methods
Cell Cultures. Cerebral cortical neurons in primary culturewere prepared from
Sprague-Dawley rat fetuses at embryonic day (E)18. The cerebral corticeswere
dissected into Hank’s balanced salt solution (HBSS). HBSS was removed and
tissues were treated with 0.25% trypsin at 37 °C for 15 minutes. Tissues were
then treatedwith 0.1%DNase I at 37 °C for 5minutes. Cellswerediluted to106
cells/ml in Dulbecco’s modified Eagle’s medium (DMEM; Sigma) containing
10% fetal bovine serum (FBS), 50 units/ml penicillin, 50g/ml streptomycin, and
2 mmol/l L-glutamine, and were seeded on plates precoated with 40 g/ml
poly-L-lysine. After 3 hours, DMEM was replaced with neurobasal medium
(GIBCO) containing B27 Supplement (GIBCO), 50 units/ml penicillin, 50 g/ml
streptomycin, and 2 mmol/l L-glutamine. Half of the cell culture medium was
replaced after 3 DIVwith neurobasal medium containing the supplements spec-
ified above and aracytine 107 mol/l.
Reagents. Reagents and concentrations, unless otherwise stated, were as
follows,: ouabain (1, 10, 100 mol/l, Sigma), nifedipine (50 mol/l, Sigma),
KN93 (20 mol/l, Tocris), and U0126 (20 mol/l, Cell Signaling).
86Rb Uptake Assay. Cortical neurons at E18  4 DIV were rinsed with phos-
phate buffered saline solution (PBS) and incubated with PBS containing
indicated ouabain concentrations for 30 minutes at 37 °C. To each well 86Rb
was added at 1.5 Ci/ml, and incubation was continued for another 10
minutes in 37 °C. Uptake was thereafter inhibited by 2 mmol/l ouabain, and
this valuewas taken as themaximal rate of active uptake. The incubationwas
stopped by rinsing the plate four times with PBS plus BaCl2 (5 mmol/l). Cells
were extracted with 0.3 ml of 1 mol/l NaOH for 10 minutes, and samples were
counted in a scintillation counter. Each data point represents the average of
the radioactivity present in four separate wells.
RT-PCR. Total RNAwas extracted from cultured rat embryonic cortical neurons at
E18  4 DIV using TRIzol reagent (Invitrogen). Single-strand cDNA was synthe-
sized from 1 g total RNA by random primers and SSII-RT (Invitrogen) and the
cDNAwas then amplified by RT-PCR with TaqDNA polymerase (Invitrogen). The
PCR reactionswereperformedas follows: 94 °C for 30 seconds, 60 °C for 30 seconds,
and72 °Cfor60seconds, repeatedfor45cycles.ThePCRproductswereseparatedon
a 1.5% agarose gel, and ethidium bromidewas used for visualization.
Calcium Imaging.Calciumexperiments on cortical neurons at E18 4DIVwere
carried out in artificial cerebrospinal fluid containing the following: 125
mmol/l NaCl, 25mmol/l NaHCO3, 1.25mmol/l NaH2PO4, 5mmol/l KCl, 2mmol/l
CaCl2, 1mmol/lMgSO4, and20mmol/l D-glucose bubbledwith 95%O2and5%
CO2 to reach a final pH of 7.3. Cells were incubated for 15–30minutes at 37 °C
with 5% CO2 in 5 mol/l Fluo-3/AM (Molecular Probes, Invitrogen). Coverslips
were mounted in a temperature controlled (37 °C) chamber (Warner Instru-
ments) and clamped onto a Zeiss Axiovert 100M microscope, equipped with a
C-Apochromat 40X/1.2NA water immersion objective (Zeiss), connected to
a Lambda LS xenon-arc lamp (Sutter), Lambda 10–3 filter-wheel (Sutter), and a
smartShutter (Sutter). Images were acquired at 0.2 Hz with an EMCCD camera
Cascade II:512 (Photometrics) controlled by the acquisition software MetaFluor
(Molecular Devices). Perfusion (1ml/min)with 95%O2-5%CO2 bubbled artificial
cerebrospinal fluid was used for Ca2 recordings on cortical neurons.
Electrophysiology. Cortical neurons in culture at E18 4 DIV were recorded in
the whole-cell configuration using a patch-clamp amplifier (AxoPatch 200A,
Axon Instruments). Neurons had an average resting membrane potential of
62.2  0.7 mV and were continuously perfused with extracellular solution
containing the following: 100 mmol/l NaCl, 2 mmol/l KCl, 1.2 mmol/l MgCl2, 2
mmol/l CaCl2, 10mmol/l glucose, and10mmol/l HEPES,withpHadjusted to 7.6
using NaOH, and 223 mOsm. The pipettes were filled with a solution contain-
ing: 90 mmol/l K-gluconate, 5 mmol/l KCl, 0.1 mol/l CaCl2, 10 mmol/l HEPES,
4mmol/lMg2ATP, 0.3mmol/l Na4GTP, and 5mmol/l phosphocreatineNa2with
pH adjusted to 7.4 using KOH, and 217 mOsm. Solutions and drugs were
applied through a gravity-driven microperfusion system, with the tip placed
close to the recorded cell.
Western Blot and Immunocytochemistry. Cortical neurons at E18 4 DIV were
exposed to various treatments. The cells were lysed using modified RIPA
buffer for 20 min at 4 °C. Protein concentration was determined using a BCA
protein assay (Pierce) andequal amounts of cellular protein (10–20g)were
separated on a 10% sodium dodecyl sulfate gel electrophoresis, followed by
a transfer to a nitrocellulosemembrane.Membraneswere blocked in 5% skim
milk in Tris-buffered saline solution plus 0.5% Tween-20 for 1 hour before
incubation with primary antibodies (Ab) (1:1000) (ERK1/2, Phospho-ERK1/2,
Ser-133 CREB, and Phospho-Ser-133 CREB, all fromCell Signaling) overnight at
4 °C and further incubation with horseradish peroxidase-conjugated second-
aryAb (1:5000) (Amersham) for 1hour. Immunoreactivebandswerevisualized
using an enhanced chemiluminescence kit (Amersham).
Immunocytochemical staining of phospho-Ser-133 CREB and MAP2 was
performed according to standard protocol, using fixation by 4% paraformal-
dehyde in 1 hour. After blocking with 1% bovine serum albumen, cells were
incubated with phospho-Ser-133 CREB Ab (1:100, Cell Signaling) or MAP2 Ab
(1:400, Chemicon) overnight and then with Alexa 488 secondary Ab (1:2000,
1:200;Molecular Probes) for 1 hour, togetherwith 0.3%Triton X-100. Nucleus
was stained with TO-PRO-3 (1:200; Molecular Probes) for 10 minutes. Slides
weremountedusing theProlongAntifadeKit (Molecular Probes) and scanned
in aZeiss LSM510 confocalmicroscopeequippedwith aC-Apochromat 40X/1.2
water immersion objective (Zeiss).
Luciferase Assay. For CREB activity assay, cortical neurons were transfected at
E18  3 DIV with pCRE-luciferase reporter (Stratagene) and pRL-TK Renilla
reporter (Promega) using Lipofectamine 2000 (Invitrogen). After 48 hours,
cells were treatedwith KN93, U0126, or nifedipine for 15minutes followed by
ouabain for 6 hours. Thereafter cells were harvested, and luciferase activity
was measured using the dual-luciferase reporter assay system (Promega).
Data Analysis.Dendritic growth was analyzed from 10 fields of view per cell
culture using ImageJ (National Institutes of Health, Bethesda, MD) to-
gether with the plug-in NeuronJ. For each field, the average dendritic
2216  www.pnas.orgcgidoi10.1073pnas.0809253106 Desfrere et al.
length and/or the number of dendrites per cell was calculated. When
recording, intracellular Ca2, cells were considered oscillating when at
least three Ca2 transients were observed exceeding 50% of the baseline.
Data are presented asmean SE of aminimumof three experiments unless
otherwise indicated. Statistical significance was accepted at P  0.05 as
determined by analysis of variance, followed by Bonferroni’s post hoc test
for multiple comparisons.
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Critical role for hyperpolarization-activated cyclic
nucleotide-gated channel 2 in the AIF-mediated
apoptosis
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Cellular calcium uptake is a controlled physiological process
mediated by multiple ion channels. The exposure of cells to
either one of the protein kinase C (PKC) inhibitors, stauros-
porine (STS) or PKC412, can trigger Ca2þ influx leading to
cell death. The precise molecular mechanisms regulating
these events remain elusive. In this study, we report that
the PKC inhibitors induce a prolonged Ca2þ import through
hyperpolarization-activated cyclic nucleotide-gated channel 2
(HCN2) in lung carcinoma cells and in primary culture of
cortical neurons, sufficient to trigger apoptosis-inducing factor
(AIF)-mediated apoptosis. Downregulation of HCN2 prevented
the drug-induced Ca2þ increase and subsequent apoptosis.
Importantly, the PKC inhibitors did not cause Ca2þ entry into
HEK293 cells, which do not express the HCN channels.
However, introduction of HCN2 sensitized them to STS/
PKC412-induced apoptosis. Mutagenesis of putative PKC
phosphorylation sites within the C-terminal domain of
HCN2 revealed that dephosphorylation of Thr549 was critical
for the prolonged Ca2þ entry required for AIF-mediated
apoptosis. Our findings demonstrate a novel role for the
HCN2 channel by providing evidence that it can act as an
upstream regulator of cell death triggered by PKC inhibitors.
The EMBO Journal (2010) 29, 3869–3878. doi:10.1038/
emboj.2010.253; Published online 29 October 2010
Subject Categories: signal transduction; differentiation & death
Keywords: apoptosis; apoptosis-inducing factor; calcium
signalling; calpain; HCN channel
Introduction
Ca2þ -mediated signal transduction regulates multiple cellu-
lar processes, including cell motility, DNA transcription,
exocytosis and cell death (Berridge et al, 1998). The physio-
logical functions are normally governed by Ca2þ oscillations,
whereas perturbation of the intracellular Ca2þ homeostasis
may lead to cell death by either apoptosis or necrosis. The
cytotoxic Ca2þ response is generally more pronounced and
sustained than physiological Ca2þ signalling and can be due
to excessive Ca2þ influx by plasma membrane ion channels,
or to inappropriate Ca2þ release from intracellular stores,
notably, the endoplasmic reticulum (Orrenius et al, 2003).
Non-small-cell lung carcinomas (NSCLC) are resistant to
conventional radio- and chemotherapy. Nevertheless, NSCLC
cells were shown to be sensitive to staurosporine (STS) and to
the more selective protein kinase C (PKC) inhibitor, PKC412
(N-benzoyl-staurosporine), both of which trigger apoptosis in
these cells (Joseph et al, 2002; Gallego et al, 2004). Recently, we
reported that STS-induced cell death signalling in NSCLC cells
involved both a stimulation of Ca2þ influx into the cells and an
increase in the intracellular level of reactive oxygen species
(ROS); both these events were required for the mitochondrial
processing and release of apoptosis-inducing factor (AIF) and
subsequent apoptosis (Norberg et al, 2008, 2010a, b).
AIF is a 62-kDa flavoprotein with NADH oxidase activity
that is anchored to the inner mitochondrial membrane. The
flavine adenine dinucleotide domain is essential for the redox
function of AIF, but it does not contribute to its apoptotic
function. To promote apoptosis, AIF must first be liberated
from its membrane anchor, generating a soluble 57-kDa AIF
fragment, that can be released from the mitochondria and
translocate to the nucleus, where it promotes chromatin
condensation and large-scale DNA fragmentation (Otera
et al, 2005; Hangen et al, 2010) AIF-mediated apoptosis is
independent of caspase activation and represents an impor-
tant cell death mechanism in neurons and cells of neuro-
endocrine origin, for example, NSCLC (Norberg et al, 2010b).
So far, it has been unclear how the PKC inhibitors trigger
Ca2þ influx into sensitive cells, and through which plasma
membrane ion channel(s) Ca2þ enters the cell. Potential
candidates are the family of hyperpolarization-activated cyc-
lic nucleotide-gated (HCN) channels. There are four HCN
channels (HCN1–4) described, which are permeable to Naþ
and Kþ (ratio 1:4) and can be inhibited by mM concentra-
tions of Csþ (Craven and Zagotta, 2006; Biel et al, 2009).
Interestingly, two of the four channels, namely, HCN2 and
HCN4, were demonstrated to also be permeable to Ca2þ , in
addition to Naþ and Kþ (Yu et al, 2004; Michels et al, 2008).
However, the physiological implications of Ca2þ signalling
through these channels are not known.
To investigate whether the HCN channels might participate
in apoptosis signalling, we used NSCLC cells and primary
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cultures of rat cortical neurons exposed to PKC412 or STS as
experimental model systems. Our data suggest that both kinase
inhibitors caused Ca2þ influx through the HCN channel 2 by
dephosphorylation of Thr549 within the internal regulatory
domain of HCN2. The imported Ca2þ triggered apoptosis
mediated by the calpain–AIF axis.
Results
PKC inhibitors trigger hyperpolarization-induced
Ca2þ entry into NSCLC cells
We have previously reported that PKC inhibitors can trigger a
Ca2þ influx from the extracellular medium into NSCLC cells
(Norberg et al, 2008). To examine which plasma membrane
Ca2þ channels might be involved in this response, we first
tested the effects of known inhibitors of the voltage-dependent
Ca2þ channels (VDCCs), such as nifedipine, Ni2þ , Ba2þ and
La3þ . None of these inhibitors could prevent STS/PKC412-
induced Ca2þ influx into the cells (Supplementary Figure S1).
The majority of the VDCCs are activated by depolarization,
and only few examples of hyperpolarization-activated Ca2þ
channels exist (Siegelbaum, 2000). To analyse if STS or PKC412
might affect the polarization of the plasma membrane, cells
were loaded with a polarization-sensitive dye, DiBAC, and
analysed by time-lapse single-cell recordings (Figure 1A) as
well as by flow cytometry (Figure 1B) Hyperpolarization was
confirmed by patch-clamp recordings (Supplementary Figure
S2). Thus, an early hyperpolarization of the cells was detected
upon exposure to any one of the two PKC inhibitors.
Next, the effects of STS/PKC412 on the intracellular Ca2þ
level in U1810 and H661 NSCLC cell lines were monitored.
Figure 1C depicts representative single-cell Ca2þ responses in
cells loaded with the Ca2þ -sensitive dye Fluo-4/AM and
exposed to either one of the kinase inhibitors. Both PKC412
and STS induced a prolonged elevation of the intracellular
Ca2þ level in the two cell lines. Yet, other kinase inhibitors,
such as Ro-31-8220 and Wortmannin, did not stimulate Ca2þ
entry into the cells (Supplementary Figure S3).
As mentioned above, only a few ion channels can be
activated by hyperpolarization. One example is the family of
HCN channels. Interestingly, two of these channels (HCN2 and
HCN4) were demonstrated to also be permeable to Ca2þ , in
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Figure 1 Protein kinase C inhibitors trigger hyperpolarization-mediated Ca2þ entry into NSCLC cells. U1810 cells were loaded with DiBAC,
exposed to 0.2–1 mM STS or 1–5mM PKC412 and analysed for the polarization of the plasma membrane using (A) confocal microscopy or
(B) flow cytometry. (C) Representative single-cell Ca2þ recordings of Fluo-4/AM-loaded cells exposed to 0.2–1 mM STS or 1–5mM PKC412.
(D) DiBAC-loaded cells were exposed to 3 mM CsCl before STS or PKC412 treatment. (E) Fluo-4/AM-loaded cells were pre-exposed to 3 mM
CsCl before STS or PKC412 treatment. Ratio F/F0 represents fluorescence intensity over baseline.
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addition to Naþ and Kþ (Yu et al, 2004; Michels et al, 2008).
However, the cellular implications of Ca2þ signalling by these
channels are not known. Therefore, the possible contribution of
HCN channels to the Ca2þ entry into cells exposed to PKC
inhibitors was investigated. First, the two NSCLC cell lines were
exposed to Csþ before treatment with STS or PKC412, then
plasma membrane polarization (Figure 1D) and the cytosolic
Ca2þ level (Figure 1E) were monitored. Preincubation with
Csþ inhibited both the hyperpolarization and the Ca2þ entry
into STS/PKC412-treated cells, suggesting that under these
conditions hyperpolarization was required for the Ca2þ influx,
and that this occurred through the HCN channel(s).
PKC inhibitor-induced Ca2þ influx through the HCN2
channel leads to cell death
To investigate whether one of the Ca2þ -permeable HCN
channels was involved in the Ca2þ import triggered by
STS/PKC412, the mRNA and protein expression of HCN2/
HCN4 was analysed by RT–PCR, immunocytochemistry
and FACS, respectively. Both HCN2 and HCN4 mRNAs
were expressed in U1810 (Figure 2A) and H661 cells
(Supplementary Figure S4). However, the protein expression
was detected only for the HCN2 channel, and the immuno-
stainings confirmed its typical plasma membrane locali-
zation (Figure 2A).
To examine the possible role of HCN channels in the PKC
inhibitor-induced Ca2þ entry, a siRNA approach was chosen.
The levels of mRNA (HCN2/HCN4) and protein (HCN2) ex-
pression after siRNA downregulation are shown in Figure 2B
(left and right panel, respectively). Next, cells were loaded with
Fluo-4/AM and exposed to either one of the two PKC inhibitors.
Representative Ca2þ traces, shown in Figure 2C, demonstrate
that HCN2, but not HCN4, depletion abolished the kinase
inhibitor-induced Ca2þ entry. To confirm this, Fluo-4/AM-
loaded cells were treated with STS/PKC412 (as in Figure 2C),
and 10 000 cells were analysed by flow cytometry (Figure 2D).
In order to exclude off-target effect of the siRNA, two distinct
non-overlapping siRNAs specific for HCN2 were used.
Obtained results confirmed that the HCN2 channel indeed is
mediating the influx of Ca2þ (Supplementary Figure S9A).
In addition, a rescue experiment was performed, in which
HCN2 was first downregulated by siRNA in U1810 cells, and
then mHCN2 was introduced. Ca2þ recordings revealed that
the original phenotype observed after treatment with STS was
restored by introducing mHCN2 (Supplementary Figure S5).
Furthermore, to investigate whether Ca2þ influx by the
HCN2 channel was sufficient to trigger apoptosis, the
siRNA approach was used before exposure of the cells to
STS/PKC412, and the number of cells with condensed nuclei
was counted. Although chromatin condensation was ob-
served in many of the control cells treated with STS
(Figure 2E, left panel), downregulation of HCN2 significantly
delayed this type of cell death manifestation (Figure 2E, right
panel). Altogether, our results indicate that the STS/PKC412-
induced Ca2þ influx by the HCN2 channel was sufficient to
trigger an apoptotic response in NSCLC cells.
Ca2þ entry through HCN2 channels triggers
caspase-independent, AIF-mediated cell death
To examine the mechanism of cell death that was triggered by
the Ca2þ influx through the HCN2 channel, we first analysed
if calpain was activated by monitoring the cleavage of two
selective calpain substrates, Atg5 (Figure 3A) (Yousefi et al,
2006) and AIF (Figure 3B), in control cells and cells depleted
of HCN2 channels. As shown in Figure 3A, STS-stimulated
Atg5 proteolysis was not observed in cells depleted of HCN2.
Furthermore, the cleavage of AIF was also suppressed as a
result of downregulation of HCN2 (Figure 3B). Accordingly,
the mitochondrial liberation of AIF–GFP upon STS treatment
was inhibited in cells with downregulated HCN2, and
AIF remained in the mitochondria (Figure 3C). Nuclear
localization of AIF in HCN2-expressing cells was confirmed
using confocal microscopy (Supplementary Figure S9B).
Furthermore, nuclear translocation of AIF was suppressed
in cells where HCN2 was downregulated (Figure 3D). To
confirm that the calpain–AIF signalling pathway was in fact
responsible for cell death in this experimental model, four
different methods were used. First, FACS analysis of Annexin
V/PI-stained cells pre-exposed to either the pan-caspase
inhibitor (zVAD-fmk.), the selective calpain inhibitor
(PD150606), or siRNA against AIF was performed (Figure
3D and E). Second, condensed nuclei were counted under the
same conditions (Supplementary Figure S6). Third, proces-
sing/activation of caspases-2, -3, -8 -9 and cleavage of PARP
were monitored (Supplementary Figure S7). Finally, cas-
pases-3/-7-like activity was measured (Supplementary
Figure S7). In line with previous observations, all these
results confirmed that the HCN2-mediated influx of Ca2þ
triggered caspase-independent, AIF-mediated apoptosis.
Expression of HCN2 sensitizes HEK293 cells to
STS/PKC412-evoked Ca2þ influx and apoptosis
HEK293 cells are deficient of HCN channels and, therefore,
are commonly used as a model system to study heterologus
expression (Yu et al, 2004). As expected, no HCN2 protein was
detected using immunocytochemistry. Moreover, neither STS,
nor PKC412, could stimulate Ca2þ influx into these cells
(Figure 4A). Hence, we investigated if an STS/PKC412-evoked
Ca2þ response and subsequent apoptotic effects could be
introduced by expressing the HCN2 channel in HEK293 cells.
Indeed, a prolonged PKC inhibitor-induced Ca2þ influx was
observed in transfected cells harbouring the ectopic HCN2
channel (Figure 4B). As a control for the expression of HCN2,
cells were fixed and immunostained for HCN2 (Figure 4A and B,
right panels). Similar to previous observations, AIF was released
from the mitochondria upon STS exposure, only in cells expres-
sing HCN2 (Figure 4C). Next, when cells were exposed to the
kinase inhibitors and analysed by FACS using Annexin V/PI
staining, we observed that HEK293 cells survived STS or PKC412
treatment for at least 24h (Figure 4D). However, morphological
signs of cytotoxicity were detected, suggesting that they might
die in a delayed manner. Conversely, the expression of HCN2
could sensitize these cells to STS/PKC412. These data demon-
strate that HCN2 was indeed responsible for cellular Ca2þ influx
after treatment with PKC inhibitors.
Dephosphorylation of Thr549 is essential for the
prolonged Ca2þ entry through the HCN2 channel
To investigate whether the observed kinase inhibitor-induced
Ca2þ influx was regulated by a phosphorylation-dependent
mechanism, we exposed the cells to PKC activators. Pre-
treatment of cells with either one of the two different PKC
activators (TPA or PMA), before administration of STS or
PKC412, prevented the prolonged Ca2þ import through the
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HCN2 channel (Figure 5A and B and Supplementary Figure
S8). Next, the Ser/Thr phosphorylation level of the HCN2 in
open/closed states was analysed. The results revealed that the
channel is phosphorylated in control cells, and that exposure
to STS for only 2 min led to significant dephosphorylation of
the channel (Figure 5C). Furthermore, pretreatment of the cells
with a PKC activator (PMA) suppressed this decrease. In silico
analysis of the HCN2 channel revealed four putative PKC
phosphorylation sites within its internal C-terminus domain.
Alignment of human and mouse HCN2 sequences shows that
these residues are conserved among species and suggests that
the regulation of channel activity by phosphorylation might
also be conserved (Figure 5D). Site-directed mutagenesis of
each of the putative phosphorylation sites was performed, in
which Ser/Thr was substituted with Ala. The various mutants
were transfected into HEK293 cells, and as expected, record-
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ings of intracellular Ca2þ level showed that the four mutants
responded to STS or PKC412 in a similar manner as wild-type
cells (non-mutated plasmid) (Figure 5E).
The wild-type HCN2 channel is activated by hyperpolarization
and dephosphorylation triggered by PKC inhibitors. Alternatively,
the Ala mutants might be opened either by the same mechanism
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or simply due to the hyperpolarization, as they mimic a depho-
sphorylated state of the channel. To test this possibility, HEK293
cells transfected with the different mutants were hyperpolarized
by decreasing the [Kþ ] level in the incubation medium
(Figure 5F). These experiments revealed that the wild-type
cells, as well as the Thr531, Thr566 and Ser818 mutants, responded
to the hyperpolarization with a transient Ca2þ increase, similar
to what was observed using pretreatment with PKC activators,
whereas a prolonged Ca2þ elevation was observed with the
Thr549 mutant (Figure 5G). Thus, our results suggest that depho-
sphorylation of the HCN channel on residue Thr549 is pivotal for
the prolonged Ca2þ influx mediated by the HCN2 channel upon
treatment of NCSLC cells with PKC inhibitors.
PKC inhibition leads to the influx of Ca2þ through
the HCN2 channel also in cortical neurons
Current in vivo data suggest that the AIF-mediated pathway
might be particularly important for neuronal cell death (Zhu
et al, 2007a, b; Hangen et al, 2010). Hence, we decided to
investigate whether a mechanism similar to that observed in
NSCLC cells might operate in primary cultures of rat cortical
neurons. Similar to NSCLC cells, STS or PKC412 exposure
resulted in a sustained increase in the intracellular Ca2þ
level (Figure 6A). The Ca2þ influx was blocked by pre-
incubation with Csþ (Figure 6B). Next, the HCN2 protein
was downregulated using the siRNA approach (Figure 6C);
this treatment prevented PKC inhibitor-induced Ca2þ entry
(Figure 6D) and the subsequent processing of AIF (Figure 6E).
Furthermore, by assessing the number of cortical neurons with
condensed nuclei upon treatment with STS, we found that
siRNA depletion of the HCN2 channel did suppress cell death
also in this model system (Figure 6F). In summary, our results
reveal that PKC inhibitor-induced Ca2þ import through the
HCN2 channel is sufficient to trigger apoptosis also in cortical
neurons and suggest that this might be a general mechanism of
AIF activation in cell types expressing this channel.
Discussion
Intracellular Ca2þ overload can lead to apoptotic as well as
necrotic cell death, and can be due to excessive Ca2þ entry from
the extracellular milieu, impaired Ca2þ extrusion or inappropri-
ate Ca2þ release from intracellular stores. Excess Ca2þ can
cause cytotoxicity and cell death by the activation of a variety of
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degradative enzymes, including Ca2þ -dependent proteases, or
by impairment of mitochondrial function (Orrenius et al, 2003).
NSCLC cells are resistant to conventional anticancer treat-
ments, but can be killed by the PKC inhibitors, STS and
PKC412. The responsible cell death pathway involves the
influx of extracellular Ca2þ , leading to calpain-mediated
mitochondrial processing and nuclear translocation of AIF,
which causes chromatin condensation, DNA fragmentation
and apoptotic cell death (Joseph et al, 2002; Norberg et al,
2008, 2010a, b). However, the precise regulation of this me-
chanism and the identity of the plasma membrane channels
responsible for the Ca2þ entry remain elusive.
Recently, it was reported that two of the HCN channels
previously identified in the plasma membrane of multiple cell
types are also permeable to Ca2þ , in addition to Kþ/Naþ (Yu
et al, 2004; Michels et al, 2008). This finding suggested a
possible role for these channels in mediating cellular Ca2þ
influx. Unlike most other plasma membrane Ca2þ channels,
HCN channels are activated by hyperpolarization. By mon-
itoring polarization of the plasma membrane, we found that
treatment of NSCLC cells with STS or PKC412 resulted in
hyperpolarization of the plasma membrane and Ca2þ influx
into the cells (see Figure 1A, 2B and C). It was reported
previously that the Ca2þ current flow through the HCN2
channel triggered by hyperpolarization pulses is rather slow
in comparison with that seen in other Ca2þ channels (Yu
et al, 2004). In line with these reports, we observed a time-
dependent, sustained Ca2þ influx through the HCN2 channel
that was followed by a normalization of the Ca2þ level (see
Figure 1A). The imported Ca2þ caused an elevation of the
intracellular Ca2þ level that persisted for several minutes,
which was sufficient to trigger apoptosis through activation
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of the calpain–AIF axis (see Figure 2E, G and H and
Supplementary Figure S6). All these apoptotic events
occurred in a time window where caspase activation was
not yet detected (Supplementary Figure S7).
Opening of HCN channels is regulated by cAMP binding
and phosphorylation-dependent mechanisms. For instance,
tyrosine kinases of the Src kinase family have been shown to
phosphorylate HCN1, HCN2 and HCN4, resulting in a more
rapid activation of the channel (Zong et al, 2005; Biel et al,
2009). Moreover, inhibition of Ser/Thr p38 MAP kinase has
been reported to cause hyperpolarization and activation of
the HCN channel (Poolos et al, 2006). Our results suggest that
there is a constitutive phosphorylation by PKC of Thr549
within the conserved C-terminal regulatory domain of the
channel, and that the PKC inhibitors, PKC412 or STS, trigger
both hyperpolarization and dephosphorylation of Thr549.
Hence, hyperpolarization alone would only trigger a transient
Ca2þ influx through the HCN channel. Similarly, when PKC
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activators are present to prevent dephosphorylation events,
STS/PKC412 could only stimulate a transient Ca2þ response
(see Figure 5A and B). Such a Ca2þ transient has been
reported earlier to be insufficient to activate an apoptotic
response (Norberg et al, 2008). However, when Thr549 was
mutated and could no longer be phosphorylated, hyperpolar-
ization per se resulted in a prolonged Ca2þ elevation in the
absence of any drug exposure of cells. Hence, it appears that
the dephosphorylation of Thr549 is pivotal for the involve-
ment of HCN2 in cell death signalling.
There are multiple isoforms of PKC, including PKC-a and
PKC-epsilon, which have been reported to promote prolifera-
tion and survival of NSCLC cells. These PKC isoforms were
also found to be overexpressed in NSCLC. Therefore, protein
kinases C are attractive drug targets, and several PKC inhibi-
tors have been designed that are currently being investigated
in clinical trials (Reyland, 2009). Our results support this
approach, as exposure of NSCLC cells to either one of the PKC
inhibitors, STS or PKC412, led to intracellular Ca2þ elevation
and subsequent AIF-mediated cell death. In particular,
PKC412 is clinically relevant as it is currently used in combi-
nation with Cisplatin and Gemcitabine for the treatment of
patients with NSCLC, and it has been reported to interact
strongly with PKC-a, -b and -g (Reyland, 2009). Moreover,
PKC412 was shown to have greater antitumour activity in
nude mice bearing human H460 NSCLC tumour xenografts as
compared with other conventional cytotoxic agents, includ-
ing doxorubicin, cyclophosphamide, cisplatin and gemcita-
bine (Monnerat et al, 2004). Our findings might therefore
have particular implications for treatment of NSCLC.
Materials and methods
Cell culture and transient transfection
U1810 and H661 NSCLC cells were grown in RPMI-1640 medium
supplemented with 10% (v/v) heat-inactivated fetal bovine serum
(FBS), 100 U/ml penicillin, 100 U/ml streptomycin and 2% (w/v)
glutamine. HEK293 cells were grown in DMEM medium containing
10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin
and 100 U/ml streptomycin. Cells were grown in a humidified 5%
CO2 atmosphere at 371C at a cell density allowing exponential
growth. For the plasmid transfections, cells were seeded on cover-
slips and on the following day transfected with either pEGFP–AIF or
pcDNA3.1–mHCN2 using the Lipofectamine 2000 reagent (Invitrogen),
according to the manufacturer’s instruction. pMitoDsRed was used
as a transfection marker.
Culture of cerebral cortical neurons
Primary cultures of cerebral cortical neurons were prepared from
Sprague–Dawley rat pups, 1–3 days old. The cerebral cortices were
dissected in Hank’s balanced salt solution (HBSS). HBSS was
removed and the tissues were treated with 0.25% trypsin at 371C for
15 min. This was followed by a 5 min treatment with 0.1% DNase I
at 371C. Cells were then diluted to 7105 cells/ml in DMEM
medium containing 10% FBS, 50 U/ml penicillin, 50mg/ml strepto-
mycin and 2 mmol/l L-glutamine, and were seeded on plates
precoated with 50mg/ml poly-L-lysine. After 3 h, DMEM was
replaced with neurobasal medium (GIBCO) containing B27 Supple-
ment (GIBCO), 50 U/ml penicillin, 50 mg/ml streptomycin and
2 mmol/l L-glutamine. Half of the cell culture medium was replaced
after three DIV with neurobasal medium containing the supple-
ments specified above and 107 mol/l aracytine.
Immunocytochemistry
Cells were seeded on coverslips, fixed for 20 min in 4%
formaldehyde at 41C and then washed with PBS. Incubations with
primary antibodies diluted (1:400) in PBS containing 0.3% Triton
X-100 and 0.5% bovine serum albumin (BSA) were performed
at 41C overnight. The slides were washed the following day with
PBS before incubation with secondary antibodies (1:200) at
room temperature for 1 h. Nuclei were counterstained with DAPI
(10mg/ml) by 5 min incubation at room temperature. The follow-
ing primary antibodies were used: rabbit anti-HCN2 (Alomone),
goat anti-HCN2 and goat anti-HCN4 (Santa Cruz Biotechnology).
Secondary FITC-conjugated antibodies (Molecular probes) were
directed to goat (Alexa 488). Stained slides were mounted using
Vectashield H-1000 (Vector Laboratories Inc.) and examined under
a Zeiss LSM 510 META confocal laser scanner microscope (Zeiss).
Immunoblotting
Equal amount of the protein samples were mixed with loading
buffer, boiled for 5 min, and subjected to 15% SDS–PAGE at 40 mA
followed by transfer to nitrocellulose membranes for 90 min at
120 V. Membranes were blocked for 30 min with 5% non-fat milk in
TBS at room temperature and subsequently probed with rabbit anti-
cleaved Atg5 (Abgent), goat anti-AIF (Santa Cruz Biotechnology),
rabbit anti-actin (Sigma) or rabbit anti-HCN2 (Alomone). ECLTM
(Amersham Biosciences) was used for revealing the blots. The
primary antibodies were diluted in TBS containing 1% BSA, 0.05%
Tween-20 and 0.1% NaN3. Horseradish peroxidase-conjugated
secondary antibodies (Pierce) were diluted in 2.5% blocking buffer.
Live cell imaging
To perform Ca2þ or polarization measurements the cells were
incubated (30 min at 371C in 5% CO2) in KREBS medium containing
5 mM Fluo-4/AM (Molecular Probes) together with 0.1% Pluronic
F-127 (Molecular Probes) or 150 nM DiBac. The Hepes medium
contained 130 mM NaCl, 4.7 mM KCl, 1.3 mM CaCl2, 1 mM MgSO4,
1.2 mM KH2PO4, 20 mM Hepes (pH 7.4) and 5 mM dextrose.
Hyperpolarization that was induced by decreasing the extracellular
Kþ -level was performed as follows. Cells were incubated in 500ml
KREBS medium and subsequently the Kþ concentration was decreased
to 17% (783mM) by the addition of Kþ -free KREBS. Images were
acquired at 0.2 Hz. During the time-lapse experiments all drugs were
bath-applied and examined under a Zeiss LSM 510 META scanning
laser confocal microscope (Zeiss). The following drugs were used:
0.2–1mM STS and 1–5 mM PKC412, 1mM TPA and 300 nM PMA.
Flow cytometry
Cells were loaded with DiBac or Fluo-4/AM as described above and
treated with 1mM STS or 3 mM PKC412 immediately before FL-1
FACS analysis of 10 000 cells. Cell death was assessed using the
Annexin V-FLUOS staining kit (Roche), according to the manu-
facturer’s instruction.
For analysis of HCN2 and HCN4 staining, cells were washed in
PBS and fixed with 0.25% paraformaldehyde for 10 min at room
temperature. Next, cells were stained with HCN2 and HCN4
antibodies as described in Materials and methods section, and
Immunocytochemistry.
RNA isolation and RT–PCR
Total RNA was isolated from U1810 or H661 cells using the RNeasy
kit (Qiagen). The quality of the RNA was controlled by gel electro-
phoresis of 18S and 28S ribosomal RNA. For the first-strand cDNA
synthesis, the RevertAidTM M-MuL V RT enzyme (Fermentas) was
used in combination with gene-specific primers according to
the manufacturer’s instruction. The PCR was performed using
the PlatinumsPfx DNA polymerase system (Invitrogen) and the
following specific primers (Invitrogen): HCN2 (forward primer,
CGGCCCAGTGGCTGAGAGGA; reverse primer, CACTGCTGCCTCG
GCTCGTC), HCN4 (forward primer, GGCCACTTCCACAAGGCGCT;
reverse primer, CACAAGGGACGGCGGCTCAG), G3PDH (forward
primer, CCTGGCCAAGGTCATCCATG; reverse primer CTGACACGTT
GGCAGTGGG). The conditions for HCN2 and G3PDH PCR reactions
were as follows: 941C for 1 min (hot start) followed by 951C for
1 min, 551C for 30 s and 721C for 1 min. For the PCR of HCN4 571C
was used as annealing temperature. Samples were removed every
fifth cycle to ensure exponential growth of the PCR product, which
was then analysed on a 1% agarose gel.
Measurement of caspases-3/-7-like activity
The measurement of caspase substrate (Peptide Institute, Osaka,
Japan) cleavage was performed as follows: 2106 cells were
washed once with PBS, resuspended in 25ml of PBS and placed on a
microtiter plate. Cells were subsequently mixed with DEVD-AMC
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(50 mM), dissolved in standard reaction buffer (100 mM Hepes, pH
7.25, 10% sucrose, 10 mM DTT, 0.1% CHAPS). Cleavage of the
fluorogenic peptide substrate was monitored by AMC liberation in a
Fluoroscan II plate reader (Thermo Electron Co., Waltham, MA,
USA) using 355 nm excitation and 460 nm emission wavelengths.
siRNA approach
Silencing of HCN2, HCN4 and AIF expression was achieved by
transfection of anti-HCN2 (ONTARGETplus SMARTpool L-006201-00-
0005, Dharmacon), anti-HCN4 (ONTARGETplus SMARTpool L-006203-
00-0005, Dharmacon) and anti-AIF (PDC8) (ONTARGETplus SMART-
pool L-011912-00-0005, Dharmacon) using INTERFERIN siRNA trans-
fection reagent (Polyplus transfection). The level of the mRNAs was
monitored by RT–PCR and the level of protein by western blot.
Site-directed mutagenesis
The pcDNA3.1–mHCN2 plasmid was kindly provided by Prof
Hang-Gang Yu, West Virginia University School of Medicine,
Morgantown. Quick-change II XL Site-Directed Mutagenesis kit
(Stratagene) was used according to the manufacturer’s instructions
to generate the mutations of putative PKC phosphorylation sites
within the regulatory C-terminal domain of HCN2: T531A, T549A,
T566A, S818A. The following primers were used: T531A (forward
primer, TCACAGCCATGCTGGCAAAGCTCAAATTTG; reverse primer,
CAAATTTGAGCTTTGCCAGCATGGCTGTGA), T549A (forward primer,
CCGAGAGGGGGCCATCGGGAAGA; reverse primer, TCTTCCCGATG
GCCCCCTCTCGG), T566A (forward primer, TGAGCGTGCTCGCCAA
GGGCAACAA; reverse primer, TTGTTGCCCTTGGCGAGCACGCTCA),
S818A (forward primer, GGCCAGCAGCGCCACGCCGC; reverse primer,
GCGGCGTGGCGCTGCTGGCC). Desired substitutions were confirmed
by sequencing.
Statistical analysis
Data from at least three independent experiments are presented as
mean±s.d. Student’s unpaired t-test was used for the comparisons
between different groups. A value of Po0.05 was considered as
statistically significant.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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Abstract 
Bacillus Calmette-Guérin (BCG) is utilized as cancer therapy, mainly for urinary bladder cancer, with 
very good results for non-muscle-invasive bladder cancer. Despite the efficiency in killing the cancer 
little is known about the sub-cellular signaling pathways activated by BCG. Here we demonstrate that 
BCG inhibits urinary bladder cancer cell proliferation through a PLCβ3-dependent calcium (Ca2+) 
signal. Experiments using Ca2+ free medium also showed Ca2+ responses, thus indicating that Ca2+ 
released from internal stores were responsible for this signaling event. Depleting the endoplasmic 
reticulum (ER) Ca2+ store with cyclopiazonic acid significantly blocked the BCG-induced Ca2+ response. 
Small interference RNA knock-down of PLCβ3 or pharmacological block with U73122 or ET-18-OCH3 
stopped Ca2+ signaling and reversed the inhibitory effect of BCG on cancer cell proliferation. 
Inhibition of pertussis toxin-sensitive G-protein receptors blocked the observed effect. Labeling BCG 
with a fluorescent marker indicated that BCG targeted to the ER structure of the cell. These results 
present new actions of BCG in triggering PLC-dependent Ca2+ signaling that prohibit cancer growth of 
urinary bladder cancer cells. 
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Introduction 
Urinary bladder cancer is one of the ten most common cancer-types in the world (Jemal et al., 2009). 
The most frequent bladder cancer type is non-muscle invasive cancer, that represents 70-80 % of the 
cases (Simons et al., 2008). The initial treatment of non-muscle invasive cancer is transurethral 
resection (TUR). However, tumor recurrence occurs in up to three quarters of the patients after TUR 
and in some cases the tumor further progress to invasive muscle cancer (occurs in ~20 %) (Amling, 
2001). In order to prevent this recurrence and progression, intravesical delivery of Bacillus Calmette-
Guerin (BCG) is used. BCG was originally designed as an antituberculosis live attenuated vaccine 
prepared from Mycobacterium bovis, but has been used as an anticancer agent over three decades 
given the clinical observation of being more effective than classic chemotherapy and radiotherapy 
treatments (Kassouf and Kamat, 2004; Liu et al., 2009; Morales et al., 1976). 
 
The cellular mechanisms in urinary bladder cancer cells activated by BCG are not clearly understood. 
It is believed that BCG give rise to local immune and inflammatory responses, which leads to 
recruitment of macrophages, neutrophiles, T cells, NK cells and dendritic cells, and to increased levels 
of cytokines and chemokines that in turn may account for the cytostatic effects of BCG (Horinaga et 
al., 2005; Kamat et al., 2009; Luo and Knudson, 2010). Reports also state that BCG causes NF-κB 
transcription activation in urinary bladder cancer cells (Chen et al., 2002). 
 
The calcium ion (Ca2+) is a ubiquitous intracellular second messenger that regulates a diverse range of 
cellular processes in physiological and pathological conditions (Berridge et al., 1998; Clapham, 2007). 
The temporal and spatial features of intracellular Ca2+ signals are controlled by channels and pumps 
that transport Ca2+ through the plasma membrane or between the cytoplasm and the endoplasmic 
reticulum (ER) (Berridge et al., 2003; Norberg et al., 2010). Release of Ca2+ from intracellular ER Ca2+ 
stores mainly occurs through the inositol 1,4,5-trisphosphate (InsP3) receptors (InsP3Rs) which are 
activated when PIP2 is cleaved by Phospholipase C (PLC) into InsP3 and diacylglycerol. The subsequent 
elevation of cytosolic Ca2+ concentration activates downstream effectors, including protein kinases 
and transcription factors (Desfrere et al., 2009; Norberg et al., 2010), which in turn regulates multiple 
cellular processes. 
 
In this study we show that BCG elevates the cytosolic concentration of Ca2+ in human urinary bladder 
cancer cells. This signaling cascade involves PLCβ3 as pharmacological inhibition or small interference 
RNA-mediated gene silencing as well as ER store depletion abrogates the response. Our results also 
demonstrate that BCG blocks cancer cell proliferation in a Ca2+- and PLC-dependent manner. 
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 Results 
BCG induces an intracellular Ca2+ response in human urinary bladder cells 
Human bladder cancer cells (T24) were loaded with a Ca2+-sensitive fluorescent dye Fluo-3/AM (Fig. 
1A) to investigate how the Ca2+ homeostasis was affected by BCG. Untreated cells showed a stable 
baseline with little spontaneous Ca2+ activity (Fig. 1B). The viability of the cells under our 
experimental conditions was tested by exposing the cells to an agonist towards the end of the 
experiment. Indeed ATP, a purinergic receptor agonist, triggered a prominent Ca2+ transient after 
recording a baseline for 30 minutes (Fig. 1C). Treating the cells with BCG rapidly induced a Ca2+ 
response that could be divided into an oscillating, transient, or sustained response (Fig. 1D and 1H) 
(responses see supplementary figure 1). The contribution of extracellular Ca2+ was next tested by 
removing Ca2+ from the extracellular medium. The BCG stimulated Ca2+ response still remained in the 
absence of extracellular Ca2+ (Fig. 1E and 1H), indicating the intracellular Ca2+ was the source. Also 
the renal cell carcinoma line KU-19-20 responded with elevated Ca2+ following BCG (Fig. 1F), thus 
showing that the observed effect was not unique to T24 cells. It is known that peptidoglycan (PGN), a 
polymer found in the bacterial cell wall (Rogers HJ, 1980) consisting of N-acetylglucosamine and N-
acetylmuramic acid, can stimulate Ca2+ signaling in macrophages and dendritic cells through PLCγ2 
(Aki et al., 2008). Applying PGN to T24 cells evoked Ca2+ oscillations similar to those triggered by BCG 
(Fig. 1G). These data show that BCG can stimulate cytosolic Ca2+ signaling that partially originates 
from release of Ca2+ from internal stores. 
 
Thereafter BCG was labeled with the fluorescent non-nucleic BacLight Red stain to examine the 
binding target in the cell. Using a confocal microscope BacLigth stained-BCG were shown to interact 
with a sub-cellular target located outside the nucleus (Fig. 2A), resembling the ER structure. 
Therefore cells were double-stained with the ER marker ER-Tracker (Fig. 2B) and imaged 
simultaneously with BacLight-stained BCG. These results revealed a co-localization between BacLight-
stained BCG and ER (Fig. 2D). 
 
PLC is affecting BCG induced Ca2+ singling 
Pharmacological experiments were conducted to examine the downstream cellular signaling 
pathway of BCG. Pre-incubation with the Ca2+ chelator BAPTA suppressed the BCG-induced Ca2+ 
response (Fig. 3A). Cyclopiazonic acid (CPA) that blocks the sarcoplasmic/endoplasmic reticulum 
calcium (SERCA) pump was used to investigate the involvement of intracellular ER Ca2+ stores in BCG-
induced Ca2+ signaling. CPA caused a transient Ca2+ increase as internal ER stores were emptied (Fig. 
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3B). Depleting ER stores significantly suppressed the Ca2+ response triggered by BCG (Fig. 3B and I). 2-
Aminoethoxydiphenyl borate (2-APB) was next used to inhibit InsP3Rs. Following pre-treatment with 
2-APB reduced the number ofcells responding to BCG (Fig. 3D). 
 
PLC is involved in the production of InsP3, which stimulates Ca2+ release from the InsP3R. Therefore 
PLC was blocked with the two different PLC inhibitors U73122 and ET-18-OCH3. Both these inhibitors 
significantly reduced the BCG-induced Ca2+ response (Fig. 3D, E, and I). In contrast, U73122´s inactive 
analogue U73343 failed to block the Ca2+ response (Fig. 3F and I). Also the involvement of 
phosphatidylinositol 3-kinases (PI3Ks), an enzyme family involved in proliferation and cell growth, 
was investigated. Inhibiting PI3Ks with Wortmannin did not influence the BCG-triggered Ca2+ 
response (Fig. 3G and I). Preincubation with the G-protein coupled receptor (GPCR) inactivator 
Pertussis toxin (PTX) for 6 h prior BCG application suppressed the increase in Ca2+ (Fig. 3H and I).  
 
Small interfering RNA (siRNA) against PLC was used to further elucidate the signaling pathway 
activated by BCG. PLC can provoke intracellular Ca2+ increase through InsP3 production via two major 
pathways. One pathway involves PLCβ that is activated through GPCR, while the other pathway 
involves PLCγ that is activated by receptor tyrosine kinase (RTK). Four different isoforms of PLCβ 
exist, of which PLCβ2, PLCβ3 and PLCβ4 were expressed in T24 cells (Fig. 4A), as shown with RT-PCR. 
Since PLCβ3 is the key player in Ca2+ signaling (Hwang et al., 2005; Le Mellay and Lieberherr, 2000; 
McCullar et al., 2007) that isoform was further investigated using siRNA. Western blot analyses 
revealed a reduced protein level after 24 and 36 h with PLCβ3-siRNA (Fig. 4B). The knockdown of 
PLCβ3 significantly suppressed BCG-induced Ca2+ signaling (Fig. 4C and D). In contrast, knocking down 
PLCγ with siRNA (Fig. 4E) failed to abolish the Ca2+ response (Fig. 4F). 
 
Taken together these data suggest that PLCβ3 plays a major role in BCG stimulated Ca2+ signaling in 
urinary bladder cancer cells. 
 
The supernatant of BCG also stimulates Ca2+ singling 
The BCG mixture introduced by catheter into the patient’s bladder is diverse containing whole 
bacteria plus bacterial fragments from external cell wall, intracellular content, as well as smaller 
particles secreted from the bacteria itself. The supernatant of BCG (sBCG) was also tested on urinary 
bladder cancer cells. sBCG provoked a Ca2+ response in T24 cells (Fig. 5A and I). The sBCG response 
very much resembled the BCG response besides that fewer cells were oscillating when treated with 
sBCG (Fig. 5I). Also sBCG evoked a response independent of external Ca2+ (Fig. 5B and H). Preloading 
cells with BAPTA abolished the response (Fig. 5C and I). Inhibiting PLC with U73122 (Fig. 5D and I) or 
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ET-18-OCH3 (Fig. 5E and I) reduced the ability of sBCG to elevate cytosolic Ca2+. The inactive U73433 
had no effect on the response (Fig. 5F). Preincubation with PTX also suppressed the sBCG-induced 
Ca2+ increase (Fig. 5G and I). These data demonstrated that sBCG has a similar effect on Ca2+ signaling 
as BCG. 
 
BCG PLC-dependently affects cell proliferation 
The dependency of BCG-induced Ca2+ signaling on proliferation of urinary bladder cancer cells was 
next studied using immunocytochemistry of Ki67 and EdU (Fig. 6A). Ki67 is present in nucleus of cells 
in all active cell cycle states (G1, S, G2 and M) but is absence in resting cells (G0), while EdU detects 
cells only in the s-phase of the cell cycle. Since it is known that the immune-response is involve in the 
positive effect from BCG therapy, DSMO-differentiated human promyelotic leukemia PLB-985 cells to 
mature neutrophil-like cells were added to the T24 cells (Ashkenazi and Marks, 2009). Treatment 
with sBCG, PLB-985 or PLB-985 in addition to sBCG had no effect on Ki67 after either 48 or 72 h (Fig. 
6B). sBCG alone or in combination with PLB-985 cells did not either effect the amount of EdU positive 
cells (Fig. 6C). Neither BCG nor PLB-985 in addition to BCG had any effect on Ki67 expression (Fig. 
6D). On the other hand when looking at EdU expression, BCG independent of PLB-985 cells showed a 
decrease in the percent of EdU positive cells following 72 h treatment (Fig. 6E). These results indicate 
that the cells still remained in the cell cycle after the sBCG treatment, but fewer cells reached the s-
phase. 
 
The involvement of PLC on BCG-altered cell proliferation was next examined. The PLC inhibitor 
U73122 and its inactive analogue U73343 were applied to the cells and after 72 h of treatment with 
BCG the expression of Ki67 and EdU were detected. Neither U73122 nor U73343 alone or in 
combination with BCG influenced the Ki67 expression (Fig. 7A and B). However, when U73122 was 
added together with BCG the effect on EdU was abolished while U73343 had no effect (Fig. 7A and 
C). Taken together the treatment with the PLC inhibitor U73122 reversed the BCG-induced effect on 
EdU, as previously observed. These results suggest an additional role for PLC in modulating cell 
proliferation. 
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Discussion 
Here we show that treating urinary bladder cancer cells with BCG raises the cytosolic Ca2+ 
concentration and stops cell proliferation. This signaling event was dependent on PLCβ3 since 
pharmacological inhibition or small interference RNA-mediated gene silencing abolished the 
response. Store depletion by SERCA inhibition also blocked the BCG-triggered signal cascade. When 
cells were pre-treated with the GPCR-inhibitor pertussis toxin the response was blocked. Recoding 
EdU incorporation showed that BCG-controlled cell proliferation was mediated via a Ca2+- and PLC-
dependent mechanism. 
 
Intravesical therapy with BCG vaccine is the most effective treatment for non-muscle-invasive urinary 
bladder cancer applied today and it has been used as a routine treatment for over the last 3 decades 
(Morales et al., 1976). BCG is given in addition to transurethral resection (TUR) and has been shown 
to reduce the risk for both progression and recurrence of the cancer. Despite the frequent usage of 
BCG in the clinic, little is known about its exact actions on cells. Most cellular studies are reporting 
that BCG starts a local immune response reaction in the bladder. The immune response involves 
recruitment and migration of a large variety of immune cells e.g.; macrophages, neutrophiles, B- and 
T-cells, natural killer cells, dendritic cells to the bladder and increased levels of secreted chemokines, 
interleukins and cytokines (Horinaga et al., 2005; Kamat et al., 2009; Liu et al., 2009). However, few 
reports on non-immune responses exist. In this study it is shown that BCG also triggers a non-
immune response via Ca2+ signaling. A complete picture of BCG’s actions is needed to optimize the 
treatment and reduce unwanted side-effects. 
 
A major challenge with the BCG therapy is its unpleasant contraindications and side effects. Common 
contraindications are BCG sepsis, immune-suppression, heamaturia, active urinary tract infection and 
mild cystitis (Kresowik and Griffith, 2009). One other disadvantage with the therapy is the total 
failure in some of the patients (O'Donnell and Boehle, 2006). When the bladder cancer patients are 
given the BCG therapy they get intravesical installations with live attenuated Mycobacterium bovis 
BCG vaccine. These installations have a diverse content including whole bacteria plus fragments of 
bacteria in addition to all the components secreted from the bacteria itself. Most probably this 
diverse mixture has different effects on the cell. The data presented here show that Ca2+ signaling is 
activated by both the complete BCG as well as the supernatant of BCG. The exact effect of the BCG-
induced Ca2+ signal in the intact bladder remains to be investigated. We hypothesize that there is a 
cross-talk between the non-immune Ca2+ signal and the immune response in the in vivo setting. 
Intracellular Ca2+ signaling represent an universal mechanism in cells that is involved in regulation of 
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a variety of processes like proliferation, differentiation, gene transcription and apoptosis (Berridge et 
al., 2003). Therefore we believe that BCG-stimulated Ca2+ signaling plays a crucial role in stopping the 
progress of cancer growth in urinary bladders. In the future combination treatments of BCG together 
with pharmacological regulators of the cellular Ca2+ homeostasis might increase the efficiency of the 
treatment.  
 
Our data show that in addition to BCG also sBCG (the supernatant of centrifuged BCG) stimulates 
elevation of cytosolic Ca2+. This Ca2+ response is observed in a similar percentage of cells treated with 
sBCG as with BCG. Furthermore, both BCG and sBCG are blocked by the same inhibitors. However, a 
clear distinction between the response pattern of BCG and sBCG is observed. BCG evoked more 
oscillating cells while sBCG stimulated less oscillating cells but more transient cells. This result could 
be explained by our experiment showing that peptidoglycan (PGN), a polymer in the bacterial cell 
wall, rather induces Ca2+ oscillations. Further investigations are required to resolve all the actions of 
the BCG mixture. 
 
In this study it was demonstrated that BCG elevates the cytosolic concentration of Ca2+ in urinary 
bladder cancer cells. The signaling cascade was shown to be dependent on PLCβ3 and release of Ca2+ 
from internal ER Ca2+ stores. Our data also showed that BCG did bind a target inside the cell and that 
the supernatant of BCG as well could trigger a similar response. Inhibiting pertussis toxin-sensitive 
GPCRs blocked the BCG-induced Ca2+ response. Recoding EdU incorporation showed that BCG-
controlled cell proliferation was mediated via a Ca2+- and PLC-dependent signaling mechanism. 
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Material and Methods 
Cell culture 
Human T24 urinary bladder cells and human promyelotic leukemia PLB-985 cells were cultured in 
RPMI 1640 media containing 10% fetal bovine serum (FBS), 50 units/ml penicillin, 50 μg/ml 
streptomycin and 2 mmol/l L-glutamine and grown at 37°C with 5% CO2. 
 
BacLight staining 
A 100 µM BacLight Red (Molecular Probes, Invitrogen) solution was diluted 1:1000 in the bacterial 
sample and incubated for 15 min at room temperature before addition to the cells and overnight 
incubation in 37°C with 5% CO2. Cells were double stained with ER-tracker (Molecular Probes, 
Invitrogen) before being monitored using an Olympus FluoView 1000, confocal laser scanning 
microscope. 
 
Calcium imaging 
Cells were loaded with the Ca2+-sensitive fluorescence indicator Fluo-3/AM (5 µM, Molecular-Probes, 
Invitrogen) in Krebs Ringer’s solution at 37°C with 5% CO2 for 30 min. The Ca2+ measurements were 
conducted at 37°C in a heat-controlled chamber (QE-1, Warner Instruments) with a confocal 
microscope Zeiss LSM510NLO META (Carl Zeiss) equipped with a 20x/0.8NA dipping lens (Carl Zeiss). 
Excitation was set at 488 nm and emission wavelengths were detected at 510 nm. The sampling 
frequency was set to 0.1 Hz. Carl Zeiss software (Carl Zeiss) was used to analyze the acquired images. 
The experiments were performed in Krebs-Ringer’s buffer containing 119.0 mM NaCl, 2.5 mM KCl, 
2.5 mM CaCl2, 1.3 mM MgCl2, 1.0 mM NaH2PO4, 20.0 mM Hepes (pH 7.4), and 11.0 mM dextrose. 
Drugs were bath-applied. 
 
5-ethynyl-2´-deoxyuridine (EdU) staining and immunocytochemistry  
Cells were seeded on gelatin coated 13 mm coverslips in a 24 well plate at a concentration of 20 ×103 
cells/ml. After 48 or 72 h of BCG treatment, the cells were puls-labeled with 50 µM EdU for 1-2 h and 
fixed with 4% PFA. The cells were blocked with PBS containing 0.3% triton and 3% BSA for 1 h at 
room temperature, and incubated with the primary antibody (Ki67 1:200, NeoMarkers) at 4°C 
overnight. Cells were then washed three times with PBS-triton and incubated with secondary 
antibody (Alexa 555 goat anti rabbit 1:1000, Invitrogen). EdU incorporation was subsequently 
detected by incubation with a reaction-mix (TRIS pH 8.8, CuSo4, Alexa-azide 488, ascorbic acid) for 30 
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min at room temperature protected from light. Cells were washed with PBS-triton and stained with 
TO-PRO3 (Molecular Probes, Invitrogen) for 5 min before mounted. The samples were evaluated with 
a Carl Zeiss LSM5 Exciter confocal microscope. 
 
siRNA transfection 
siRNA against PLCβ3 and PLCγ (Dharmacon) was used to reduce protein levels. T24 cells were seeded 
in 25 mm plates to 60% confluency and transfected with siRNA (100 µM) using Lipofectamine 2000 
(Invitrogen) in Opti-MEM (Invitrogen) according the manufacturer's instructions. Down regulation of 
PLCβ3 and PLCγ was confirmed by Western blot analysis.  
 
Western blotting 
After adequate treatment cells were lysed using modified RIPA buffer for 20 min at 4°C. Equal 
amounts of protein were separated on a 10% sodium dodecyl sulfate gel electrophoresis, followed by 
a transfer to a PVDF membrane. The membranes were blocked in 5% milk or BSA in TRIS-buffered 
saline solution plus 0.5% Tween-20 for 1 h before incubation with primary antibodies (PLCβ3, 1:1000; 
PLC γ, 1:1000; β-actin, 1:1000, Abcam) overnight at 4°C and further incubation with secondary 
antibodies (1:5000) for 1 h. Bands were detected with a chemiluminescence kit (Amersham) and 
visualized using Biorad. 
 
Statistical analysis 
The Ca2+ recording data were normalized and cells were considered responsive to a treatment if the 
mean fluorescence was increased by at least 50% over the baseline. All the data were presented as 
means ± SEM. Oneway ANOVA was used and significance was accepted at P < 0.05. 
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Legends 
Figure 1| BCG elevates cytosolic Ca2+ in human urinary bladder cells. (A) Human urinary bladder 
cancer cells, T24, were loaded with the Ca2+-sensitive fluorescent dye Fluo-3/AM. Representative 
single cell Ca2+ recordings are shown in B to G. (B) Baseline Ca2+ recording of untreated cells showed 
no spontaneous activity. (C) Viability test with the purinergic receptor agonist ATP (10 µM) rapidly 
induced a Ca2+ transient. BCG stimulation provoked a Ca2+ response in both presence (D) and absence 
(E) of extracellular Ca2+. (F) BCG induced a similar Ca2+ response in a different cell model, renal KU-19-
20 cells. (G) Stimulation with PGN (250 000 units/ml) evoked an analogous Ca2+ response pattern as 
BCG did. (H) Statistical analyses of the different types of Ca2+ response to BCG in the presence and 
absence of extracellular Ca2+. Data in the graph are presented as mean ± SEM (n ≥ 11). Ratio F/F0 
represents fluorescence intensity over baseline. 
 
Figure 2 | BCG binds to target(s) that appear to locate to the ER. Confocal microscopy images of 
cells incubated overnight with BCG stained with BacLight (A) and loaded with ER-tracker (B). Bright 
field (D) and merged images (D) show that BCG co-localizes with the ER. Lower panels show indicated 
zoomed area from upper panels. 
 
Figure 3 | The BCG-induced response involves release of Ca2+ from intracellular ER Ca2+ stores. Cells 
were preincubated with indicated inhibitors and treated with BCG (arrow). (A and I) The Ca2+ chelator 
BAPTA (10 µM) significantly abolished the Ca2+ response. Depleting intracellular Ca2+ stores with the 
SERCA pump inhibitor CPA (50 µM) completely inhibited the Ca2+ response (B and I) while the InsP3R 
and store operated Ca2+ channel blocker 2APB (100 µM) entirely inhibited Ca2+ oscillations but had no 
effect on the transient response (C and I). Inhibition with the two PLC inhibitors U73122 (2-4 µM) (D 
and I) and ET-18-OCH3 (2-4 µM) (E and I) completely blocked the Ca2+ increase. Neither the inactive 
U73122 analogue U73343 (2-4 µM) (F and I) nor the PI3K antagonist Wortmannin (1 µM) (G and I) 
had any effect, whereas the GPCR inactivator Pertussis toxin (PTX, 1 µg/ml) 6 h prior to BCG 
suppressed the BCG induced Ca2+ response (H and I). (I) Statistical analyses of different type of BCG-
induced Ca2+ responses in urinary bladder cancer cells. Data in the graph are presented as mean ± 
SEM (n ≥ 6). * P < 0.05 (Dunn's Method). All experiments were carried out in extracellular Ca2+ free 
solution. 
 
Figure 4 | PLCβ3 knockdown abolishes BCG-induced Ca2+ signaling. (A) RT-PCR of the PLCβ subunit 
isoforms in T24 cells showed mRNA expression of PLCβ2-4 (PB1-4). Amplification of TBP and NAPDH 
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were used as controls. (B) Western blot analysis of PLCβ3 expression showed downregulation of 
protein levels after treatment with siRNA-PLCβ3 (100 nM) for 24, 36, 48 h. (C) The BCG-induced Ca2+ 
response was suppressed in cell transfected with siRNA-PLCβ3 for 36 h. (D) Statistical analyses of 
siRNA-PLCβ3 transfected cells treated with BCG. Data are means ± SEM (n ≥ 4). * P < 0.05 (Dunn's 
Method). (E) Western blot analysis of PLCγ expression showed downregulation of protein levels after 
treatment with siRNA-PLCγ (100 nM) for 36 h. (F) The BCG-induced Ca2+ response was still present in 
cell transfected with siRNA-PLCγ for 36 h. 
 
Figure 5 | The supernatant of BCG also stimulates Ca2+ signaling. Cells loaded with Fluo-3/AM were 
preincubated with indicated inhibitors and treated with the supernantant of BCG (sBCG, arrow). Cells 
showed a response to sBCG both in presence (A and I) and absence (B and I) of extracellular Ca2+. The 
Ca2+ chelator BAPTA (10 µM) (C and I) and the PLC inhibitors U73122 (2-4 µM) (D and I) and ET-18- 
OCH3 (2-5 µM) (E and I) all suppressed the sBCG-induced Ca2+ response. (F and I) The U73122 
analogue U73343 had no effect on the BCG response. (G and I) Pertussis toxin (PTX, 1 µg/ml) 6 h 
prior to BCG reduced the Ca2+ response. Experiments in B to G were performed in extracellular Ca2+ 
free solution. Statistical analyses of the different types of Ca2+ responses induced by sBCG with and 
without extracellular Ca2+ (H) and with various inhibitors (I). Data are presented as means ± SEM (n ≥ 
12 in H) and (n ≥ 4 in I). *P < 0.05 (Dunn's Method). 
 
Figure 6 | BCG inhibits cell proliferation of human urinary bladder cancer cells. (A) Confocal images 
of EdU (green) and Ki67 (red) in T24 cells treated with BCG/sBCG plus or minus promyelotic leukemia 
PLB-985 cells for 48 or 72 h. Nuclear staining with TO-PRO3 (blue). Treatment with sBCG alone or in 
combination with PLB-985 cells did not influence the expression levels of either Ki67 (B) or EdU (C). 
BCG alone or in combination with PLB-985 cells had no effect on Ki67 (D) whereas BCG significantly 
decreased EdU expression independently of PLB-985 (E). Data are means ± SEM (n = 3). * P < 0.05 
(Holm-Sidak method). 
 
Figure 7 | PLC critically regulates BCG-controlled cell proliferation. (A) Confocal images of EdU 
(green) stained cells treated with BCG plus or minus U73122 or U73343 for 72 h. Nuclear staining 
with TO-PRO3 (blue). Treatment with BCG plus or minus U73122 or U73343 had no effect on the Ki67 
expression (B) whereas treatment with U73122 abolished BCG’s effect on EdU expression (C). Data 
are means ± SEM (n = 8). * P < 0.001 (Holm-Sidak method). 
 







